Release – Capstone Green Energy Corporation to Provide 1 MW Biogas Power System for Wastewater Treatment Facility in Central America

 


Capstone Green Energy Corporation (NASDAQ:CGRN) to Provide 1 MW Biogas Power System for Wastewater Treatment Facility in Central America

 

Renewable Fuel Projects Made up 13% of Total Revenues in Fiscal 2021

VAN NUYS, CA / ACCESSWIRE / August 4, 2021 / Capstone Green Energy Corporation (www.CapstoneGreenEnergy.com) (NASDAQ:CGRN) formerly Capstone Turbine Corporation (www.capstoneturbine.com) (NASDAQ:CPST) (“Capstone” or the “Company”), announced today that its Direct Solution Sales Team received a contract for a Capstone Signature Series C1000S system to operate grid-connected on biogas at a wastewater treatment facility in Central America.

The new system, currently slated to be commissioned in November 2021, is expected to allow the site to reduce the amount of electricity needed to be purchased from the local utility. As a biogas-based system, the configuration will capture the methane produced by the anaerobic digesters and use it to fuel the C1000S system. Due to the coastal location, the system will include a high humidity enclosure, which minimizes the effects of the climate and helps ensure equipment reliability.

“Thanks to the anaerobic digesters, the plant essentially has access to free fuel. In addition, the methane produced will no longer need to be flared off into the atmosphere, which will reduce the plant’s emissions and improve air quality for local communities,” said Jim Crouse, Capstone Green Energy Chief Revenue Officer.

Capstone has appointed DTC Machinery, the Company’s distributor in Central America, to provide support once the system is installed and commissioned.

According to the Environmental and Energy Study Institute (EESI),biogas can provide a clean, renewable, and reliable source of baseload power in place of coal or natural gas. Renewable baseload power can complement more intermittent renewables. Similar to natural gas, biogas can also be used as a source of peak power that can be rapidly ramped up. Using stored biogas limits the amount of methane released into the atmosphere and reduces dependence on fossil fuels. The reduction of methane emissions derived from tapping all the potential biogas in the United States is estimated to be equal to the annual emissions of up to 11 million passenger vehicles.

Capstone Green Energy is focused on increasing the use of biogas and other renewable fuels. In fiscal year 2021, 13% of Capstone Green Energy revenues were derived from biogas-to-energy projects or other renewable fuels. Generating electricity from biogas is a process that has been widely implemented around the world. World Biogas Association estimates that there are approximately 132,000 small, medium or large-scale digesters operating in the world, providing a large-scale global opportunity for implementing new biogas-based systems.

“The addition of a biogas-based microturbine system at a wastewater treatment facility is essentially a win-win for everyone involved,” said Darren Jamison, President and Chief Executive Officer of Capstone Green Energy. “Not only does it provide long-term cost savings and environmental benefits, but it also offers greater energy independence and reliability. We believe it’s truly an ideal solution for these types of facilities,” concluded Mr. Jamison.

About Capstone Green Energy
Capstone Green Energy (www.CapstoneGreenEnergy.com) (NASDAQ: CGRN) is a leading provider of customized microgrid solutions and on-site energy technology systems focused on helping customers around the globe meet their environmental, energy savings, and resiliency goals. Capstone Green Energy focuses on four key business lines. Through its Energy as a Service (EaaS) business, it offers rental solutions utilizing its microturbine energy systems and battery storage systems, comprehensive Factory Protection Plan (FPP) service contracts that guarantee life-cycle costs, as well as aftermarket parts. Energy Conversion Products are driven by the Company’s industry-leading, highly efficient, low-emission, resilient microturbine energy systems offering scalable solutions in addition to a broad range of customer-tailored solutions, including hybrid energy systems and larger frame industrial turbines. The Energy Storage Products business line designs and installs microgrid storage systems creating customized solutions using a combination of battery technologies and monitoring software. Through Hydrogen Energy Solutions, Capstone Green Energy offers customers a variety of hydrogen products, including the Company’s microturbine energy systems.

For customers with limited capital or short-term needs, Capstone offers rental systems; for more information, contact: [email protected]. To date, Capstone has shipped over 10,000 units to 83 countries and estimates that, in FY21, it saved customers over $217 million in annual energy costs and approximately 397,000 tons of carbon. Total savings over the last three years are estimated at 1,115,100 tons of carbon and $698 million in annual energy savings.

For more information about the Company, please visit: www.CapstoneGreenEnergy.com. Follow Capstone Green Energy on TwitterLinkedInInstagramFacebook, and YouTube.

Cautionary Note Regarding Forward-Looking Statements
This release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, including statements regarding expectations for green initiatives and execution on the Company’s growth strategy and other statements regarding the Company’s expectations, beliefs, plans, intentions, and strategies. The Company has tried to identify these forward-looking statements by using words such as “expect,” “anticipate,” “believe,” “could,” “should,” “estimate,” “intend,” “may,” “will,” “plan,” “goal” and similar terms and phrases, but such words, terms and phrases are not the exclusive means of identifying such statements. Actual results, performance and achievements could differ materially from those expressed in, or implied by, these forward-looking statements due to a variety of risks, uncertainties and other factors, including, but not limited to, the following: the ongoing effects of the COVID-19 pandemic; the availability of credit and compliance with the agreements governing the Company’s indebtedness; the Company’s ability to develop new products and enhance existing products; product quality issues, including the adequacy of reserves therefor and warranty cost exposure; intense competition; financial performance of the oil and natural gas industry and other general business, industry and economic conditions; the Company’s ability to adequately protect its intellectual property rights; and the impact of pending or threatened litigation. For a detailed discussion of factors that could affect the Company’s future operating results, please see the Company’s filings with the Securities and Exchange Commission, including the disclosures under “Risk Factors” in those filings. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, changed circumstances or future events or for any other reason.

CONTACT:
Capstone Green Energy
Investor and investment media inquiries:
818-407-3628
[email protected]

SOURCE: Capstone Green Energy Corporation

Release – TherapeuticsMD Announces Second Quarter 2021 Financial Results


TherapeuticsMD Announces Second Quarter 2021 Financial Results

 

– 2Q21 total net product revenue increased by 17% over 1Q21 to 
$23 million –

– ANNOVERA® prescription growth supported by improved access to providers and increased telemedicine options for patients –

– Prescriptions for IMVEXXY® grew by 8% over 1Q21, outpacing the VVA market –

– 
Centers for Medicare and Medicaid Services recommended that ANNOVERA receive its own unique national J-Code that could be live as early as Q421 –

– vitaCare signed new customer and pipeline continues to grow –

– Conference call scheduled for 
8:30 a.m. ET today –

BOCA RATON, Fla.–(BUSINESS WIRE)–Aug. 4, 2021– 
TherapeuticsMD, Inc. (“TXMD” or the “Company”) (NASDAQ: TXMD), an innovative, leading women’s healthcare company, today reported financial results for the second quarter ended 
June 30, 2021.

“We continue to make steady progress in line with our expectations related to ANNOVERA and IMVEXXY driving prescription growth, net margins and broader patient access. Importantly, we are seeing improved access to health care providers for our sales force and expansion of our relationships in the telemedicine channel and believe we are well positioned to grow our products across all channels. Our overall volumes and net revenues were very healthy, and vitaCare prescription services is building the foundation for growth in the future. vitaCare recently signed its third customer contract and has a strong pipeline of more than 30 potential customers. In addition, we continue to evaluate investment into vitaCare, including potentially selling a minority stake, which could provide a non-dilutive source of capital for TXMD shareholders,” said  Robert G. Finizio, Chief Executive Officer of 
TherapeuticsMD.

Second Quarter 2021 Financial Results and Business Highlights

Net Product Revenue

Three Months Ended

June 30,

March 31,

2021

2020

2021

ANNOVERA

$

9,555

$

1,835

$

8,750

IMVEXXY

 

9,838

 

5,086

 

7,012

BIJUVA

 

2,156

 

1,352

 

2,445

Prescription vitamin

 

1,452

 

2,428

 

1,425

Product revenue, net

 

23,001

 

10,701

 

19,632

License revenue

 

 

 

234

Total revenue, net

$

23,001

$

10,701

$

19,866

ANNOVERA (segesterone acetate and ethinyl estradiol vaginal system)

  • ANNOVERA net product revenue of 
    $9.6 million for the second quarter of 2021 increased by 
    $7.7 million compared to 
    $1.8 million for the second quarter of 2020 and 
    $0.8 million compared to 
    $8.8 million for the first quarter of 2021.
  • Net revenue per unit, calculated from sales to wholesalers and pharmacies, was 
    $1,157 for the second quarter of 2021.
  • Approximately 7,299 ANNOVERA prescriptions were dispensed to patients during the second quarter of 2021. Prescriptions increased 202% compared to the second quarter of 2020 and 17% compared to the first quarter of 2021. Refill rates remained strong at approximately 50% for eligible patients.

IMVEXXY (estradiol vaginal inserts)

  • IMVEXXY net product revenue of 
    $9.8 million for the second quarter of 2021 increased by 
    $4.8 million compared to 
    $5.1 million for the second quarter of 2020 and 
    $2.8 million compared to 
    $7.0 million for the first quarter of 2021.
  • Net revenue per unit, calculated from sales to wholesalers and pharmacies, was 
    $64 for the second quarter of 2021, reflecting a 56% improvement in net price compared to the second quarter of 2020. This is the fourth consecutive quarter that IMVEXXY has achieved a record net revenue per unit.
  • Approximately 117,000 IMVEXXY prescriptions were dispensed to patients during the second quarter of 2021. Total prescriptions increased by 8% from the first quarter of 2021. IMVEXXY fill rates remained above category averages at approximately 4.4 fills per year with over 20% of patients filling a 90-day supply.
  • New telemedicine relationship with UpScript is designed to provide increased patient access to IMVEXXY with the potential to improve conversion to prescription in the online channel.
  • The recently launched direct-to-consumer campaign for IMVEXXY, Long  May She Reign, has had a positive impact on both interest and engagement.

BIJUVA (estradiol and progesterone)

  • BIJUVA net product revenue of 
    $2.2 million for the second quarter of 2021 increased by 
    $0.8 million compared to 
    $1.4 million for the second quarter of 2020 but decreased by 
    $0.3 million compared to 
    $2.4 million for the first quarter of 2021.
  • Net revenue per unit, calculated from sales to wholesalers and pharmacies, was approximately 
    $68 for the second quarter of 2021.
  • Approximately 31,900 BIJUVA prescriptions were dispensed to patients in the second quarter of 2021. Total prescriptions increased by 3.5% from the first quarter of 2021.
  • BIJUVA received approval in seven European countries.
  • BIJUVA 0.5/100 received a PDUFA date of 
    March 21, 2022.

Cost of Goods Sold and Gross Margin

  • Cost of goods was 
    $4.1 million with gross margin of 82% for the second quarter of 2021 compared to 
    $4.4 million with gross margin of 59% for the second quarter of 2020 and 
    $4.7 million with gross margin of 76% for the first quarter of 2021. The improvement in the Company’s gross margin for the second quarter of 2021 from the second quarter of 2020 and first quarter of 2021 was mainly attributable to an inventory obsolescence charge in the second quarter of 2020 and the first quarter of 2021.

Operating Expense, Net Loss and Related Information

  • Total operating expense of 
    $54.0 million for the second quarter of 2021 increased by 
    $2.7 million compared to 
    $51.3 million for the second quarter of 2020 and 
    $9.6 million compared to 
    $44.5 million for the first quarter of 2021.
  • Net loss for the second quarter of 2021 was 
    $42.7 million, or 
    $0.11 per basic and diluted share, compared to net loss for the second quarter of 2020 of 
    $52.0 million, or 
    $0.19 per basic and diluted share, and net loss for the first quarter of 2021 of 
    $39.4 million, or 
    $0.11 per basic and diluted share.

Balance Sheet

  • As of 
    June 30, 2021, the Company’s cash on hand totaled 
    $111.4 million, compared with 
    $80.5 million as of 
    December 31, 2020.
  • For the first six months of 2021, the Company received 
    $151.1 million in net proceeds from its at-the-market and underwritten equity offerings. Subsequent to quarter-end, in 
    July 2021, the Company received an additional 
    $31.8 million in net proceeds from its at-the-market offering.
  • As of 
    June 30, 2021, the remaining outstanding principal amount under the Company’s Financing Agreement was 
    $200.0 million, which reflects a repayment of 
    $50.0 million of principal during the first six months of 2021.

Conference Call and Webcast Details

TherapeuticsMD will host a conference call and live audio webcast today at 
8:30 a.m. ET to discuss these financial results and provide a business update.

Date:

Wednesday, August 4, 2021

Time:

8:30 a.m. ET

Telephone Access (US):

866-665-9531

Telephone Access (International):

724-987-6977

Access Code for All Callers:

7736027

A live webcast and audio archive for the event may be accessed on the home page or from the “Investors & Media” section of the 
TherapeuticsMD website at www.therapeuticsmd.com. Please connect to the website prior to the start of the presentation to ensure adequate time for any software downloads that may be necessary to listen to the webcast. A replay of the webcast will be archived on the website for at least 30 days. In addition, a digital recording of the conference call will be available for replay beginning two hours after the call’s completion and for at least 30 days with the dial-in 855-859-2056 or international 404-537-3406 and Conference ID: 7736027.

Please see the Full Prescribing Information, including indication and Boxed WARNING, for each 
TherapeuticsMD product as follows:

Forward-Looking Statements

This press release by 
TherapeuticsMD, Inc. may contain forward-looking statements. Forward-looking statements may include, but are not limited to, statements relating to TherapeuticsMD’s objectives, plans and strategies as well as statements, other than historical facts, that address activities, events or developments that the company intends, expects, projects, believes or anticipates will or may occur in the future. These statements are often characterized by terminology such as “believes,” “hopes,” “may,” “anticipates,” “should,” “intends,” “plans,” “will,” “expects,” “estimates,” “projects,” “positioned,” “strategy” and similar expressions and are based on assumptions and assessments made in light of management’s experience and perception of historical trends, current conditions, expected future developments and other factors believed to be appropriate. Forward-looking statements in this press release are made as of the date of this press release, and the company undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties, many of which are outside of the company’s control. Important factors that could cause actual results, developments and business decisions to differ materially from forward-looking statements are described in the sections titled “Risk Factors” in the company’s filings with the 
Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, as well as reports on Form 8-K, and include the following: the effects of the COVID-19 pandemic; the company’s ability to maintain or increase sales of its products; the company’s ability to develop and commercialize IMVEXXY®, ANNOVERA®, and BIJUVA® and obtain additional financing necessary therefor; whether the company will be able to comply with the covenants and conditions under its term loan facility; whether the company will be able to successfully divest, or obtain an investment in, its vitaCare business and how the proceeds that may be generated by any such divestiture or investment will be utilized; the potential of adverse side effects or other safety risks that could adversely affect the commercialization of the company’s current or future approved products or preclude the approval of the company’s future drug candidates; whether the FDA will approve the lower dose of BIJUVA; the company’s ability to protect its intellectual property, including with respect to the Paragraph IV notice letters the company received regarding IMVEXXY and BIJUVA; the length, cost and uncertain results of future clinical trials; the company’s reliance on third parties to conduct its manufacturing, research and development and clinical trials; the ability of the company’s licensees to commercialize and distribute the company’s products; the ability of the company’s marketing contractors to market ANNOVERA; the availability of reimbursement from government authorities and health insurance companies for the company’s products; the impact of product liability lawsuits; the influence of extensive and costly government regulation; the volatility of the trading price of the company’s common stock and the concentration of power in its stock ownership.

– Financial Statements to Follow –

 
TherapeuticsMD, Inc. and Subsidiaries
Consolidated Balance Sheets
(In thousands, except per share data)
 
 

June 30, 2021

December 31, 2020

(Unaudited)

 

Assets:
Current assets:
Cash

$

111,424

 

$

80,486

 

Accounts receivable, net of allowance for credit losses of 
$1,273 and 
$1,118 as of 
June 30, 2021 and 
December 31, 2020, respectively

 

33,481

 

 

32,382

 

Inventory

 

7,574

 

 

7,993

 

Prepaid and other current assets

 

7,178

 

 

7,543

 

Total current assets

 

159,657

 

 

128,404

 

Fixed assets, net

 

1,647

 

 

1,942

 

License rights and other intangible assets, net

 

40,206

 

 

41,445

 

Right of use assets

 

8,838

 

 

9,566

 

Other non-current assets

 

253

 

 

253

 

Total assets

$

210,601

 

$

181,610

 

Liabilities and stockholders’ equity (deficit):
Current liabilities:
Current maturities of long-term debt

$

10,000

 

$

 

Accounts payable

 

14,565

 

 

21,068

 

Accrued expenses and other current liabilities

 

51,110

 

 

38,170

 

Total current liabilities

 

75,675

 

 

59,238

 

Long-term debt, net

 

175,261

 

 

237,698

 

Operating lease liabilities

 

8,381

 

 

8,675

 

Other non-current liabilities

 

358

 

 

 

Total liabilities

 

259,675

 

 

305,611

 

Commitments and contingencies
Stockholders’ equity (deficit):
Preferred stock, par value 
$0.001; 10,000 shares authorized, none issued

 

 

 

 

Common stock, par value 
$0.001; 600,000 shares authorized, 395,048 and 299,765 issued and outstanding as of 
June 30, 2021 and 
December 31, 2020, respectively

 

395

 

 

300

 

Additional paid-in capital

 

911,511

 

 

754,644

 

Accumulated deficit

 

(960,980

)

 

(878,945

)

Total stockholders’ deficit

 

(49,074

)

 

(124,001

)

Total liabilities and stockholders’ equity (deficit)

$

210,601

 

$

181,610

 

TherapeuticsMD, Inc. and Subsidiaries
Consolidated Statements of Operations
(Unaudited – in thousands, except per share data)
 

Three Months Ended

Six Months Ended

June 30,

March 31,

June 30,

2021

2020

2021

2021

2020

Product revenue, net

$

23,001

 

$

10,701

 

$

19,632

 

$

42,633

 

$

22,952

 

License revenue

 

 

 

 

 

234

 

 

234

 

 

 

Total revenue, net

 

23,001

 

 

10,701

 

 

19,866

 

 

42,867

 

 

22,952

 

Cost of goods sold

 

4,132

 

 

4,400

 

 

4,687

 

 

8,819

 

 

7,115

 

Gross profit

 

18,869

 

 

6,301

 

 

15,179

 

 

34,048

 

 

15,837

 

Operating expenses:

 

 

Selling and marketing

 

32,164

 

 

29,887

 

 

24,024

 

 

56,188

 

 

68,683

 

General and administrative

 

19,873

 

 

18,710

 

 

18,383

 

 

38,256

 

 

37,103

 

Research and development

 

2,011

 

 

2,742

 

 

2,050

 

 

4,061

 

 

6,011

 

Total operating expenses

 

54,048

 

 

51,339

 

 

44,457

 

 

98,505

 

 

111,797

 

Loss from operations

 

(35,179

)

 

(45,038

)

 

(29,278

)

 

(64,457

)

 

(95,960

)

Other (expense) income:
Interest expense and other financing costs

 

(7,596

)

 

(7,027

)

 

(10,227

)

 

(17,823

)

 

(13,289

)

Other income, net

 

123

 

 

89

 

 

122

 

 

245

 

 

424

 

Total other (expense), net

 

(7,473

)

 

(6,938

)

 

(10,105

)

 

(17,578

)

 

(12,865

)

Loss before income taxes

 

(42,652

)

 

(51,976

)

 

(39,383

)

 

(82,035

)

 

(108,825

)

Provision for income taxes

 

 

 

 

 

 

 

 

 

 

Net loss

$

(42,652

)

$

(51,976

)

$

(39,383

)

$

(82,035

)

$

(108,825

)

Loss per common share, basic and diluted

$

(0.11

)

$

(0.19

)

$

(0.11

)

$

(0.22

)

$

(0.40

)

Weighted average common shares, basic and diluted

 

394,074

 

 

271,876

 

 

347,219

 

 

370,776

 

 

271,668

 

TherapeuticsMD, Inc. and Subsidiaries
Consolidated Statements of Cash Flows
(Unaudited – in thousands)
 
 

Six Months Ended 
June 30,

2021

2020

Cash flows from operating activities:
Net loss

$

(82,035

)

$

(108,825

)

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

 

2,061

 

 

2,019

 

Charges (credits) to provision for doubtful accounts

 

445

 

 

(182

)

Inventory charge

 

502

 

 

5,965

 

Debt financing fees

 

2,681

 

 

692

 

Non-cash operating lease expense, including impairment of 
$81 for the six months ended 
June 30, 2020

 

434

 

 

770

 

Share-based compensation

 

5,467

 

 

5,369

 

Changes in operating assets and liabilities:
Accounts receivable

 

(1,544

)

 

6,287

 

Inventory

 

(83

)

 

(4,277

)

Prepaid and other current assets

 

365

 

 

4,448

 

Accounts payable

 

(6,503

)

 

(1,911

)

Accrued expenses and other current liabilities

 

12,940

 

 

(5,420

)

Other non-current liabilities

 

358

 

 

 

Total adjustments

 

17,123

 

 

13,760

 

Net cash used in operating activities

 

(64,912

)

 

(95,065

)

Cash flows from investing activities:
Payment of patent related costs

 

(423

)

 

(816

)

Purchase of fixed assets

 

(104

)

 

(26

)

Net cash used in investing activities

 

(527

)

 

(842

)

Cash flows from financing activities:
Proceeds from sale of common stock, net of costs

 

151,062

 

 

 

Proceeds from exercise of options and warrants

 

299

 

 

166

 

Proceeds from sale of common stock related to employee stock purchase plan

 

134

 

 

 

Repayments of debt

 

(50,000

)

 

 

Borrowings of debt

 

 

 

50,000

 

Payment of debt financing fees

 

(5,118

)

 

(1,250

)

Net cash provided by financing activities

 

96,377

 

 

48,916

 

Net increase in cash

 

30,938

 

 

(46,991

)

Cash, beginning of period

 

80,486

 

 

160,830

 

Cash, end of period

$

111,424

 

$

113,839

 

 
Supplemental disclosure of cash flow information:
Interest paid

$

14,284

 

$

12,032

 

 

Edward J. Borkowski
Executive Vice President
561-961-1900

Lisa M. Wilson

In-Site Communications, Inc.
212-452-2793
[email protected]

Source: 
TherapeuticsMD, Inc.

Release – Gevos Luverne Facility Re-Starts Production Operations


Gevo’s Luverne Facility Re-Starts Production Operations

 

ENGLEWOOD, Colo., Aug. 04, 2021 (GLOBE NEWSWIRE) — Gevo, Inc. (NASDAQ: GEVO), announced today that production operations at its advanced, renewable fuels production facility located in Luverne, Minnesota (the “Luverne Facility”) have re-commenced. The Luverne Facility is expected to produce fuel-grade, renewable isobutanol (“IBA”). The IBA produced will be used as a feedstock for Gevo to produce sustainable aviation fuel and renewable premium gasoline to fulfill existing sales contracts. These renewable hydrocarbons will be produced in Silsbee, Texas at the South Hampton Resources, Inc. hydrocarbon production facility. Gevo also expects to utilize some of the IBA produced to develop certain IBA specialty markets.

Moreover, the production operations at the Luverne Facility will allow Gevo to test and evaluate certain potential unit operations that may be incorporated into Gevo’s state-of-the-art Net-Zero 1 production facility that is expected to begin production in 2024 in Lake Preston, South Dakota.

Agri-Energy, LLC, Gevo’s wholly-owned subsidiary that owns the Luverne Facility, has rehired multiple former employees and is in the process of hiring an additional 11 employees to produce the IBA with the goal to have 30 full-time employees.

“The team in Luverne has done an exceptional job restarting isobutanol operations safely and with a focus on continuous improvement for future growth,” said Dr. Paul Bloom, President of Agri-Energy, LLC. “We appreciate the continued support we’ve received from the State of Minnesota and City of Luverne and are happy to be increasing the number of high-quality jobs at the site. Ongoing production of IBA and building our team is just the first phase of what we want to do at Luverne. We see that Luverne has potential to serve specialty markets other than jet and gasoline. We expect to announce more in coming months as the rest of the plans come together.”

“We are getting geared up for what will be the next stage of Gevo’s growth which is coming at us at an accelerated rate.   We are leveraging our existing Luverne location to optimize conversion of our isobutanol production to develop the standard in operating discipline for efficient and safe IBA production facilities,” commented Dr. Patrick R. Gruber, Chief Executive Officer of Gevo. “I like the option of being able to test unit operations that could help optimize and train people for Net-Zero 1. It will be critical for Net-Zero 1 to start-up smoothly and the best way to do that is to do a good job training our people. I expect Luverne to provide some of that experience,” Dr. Gruber continued.

About Gevo

Gevo’s mission is to transform renewable energy and carbon into energy-dense liquid hydrocarbons. These liquid hydrocarbons can be used for drop-in transportation fuels such as gasoline, jet fuel and diesel fuel, that when burned have potential to yield net-zero greenhouse gas emissions when measured across the full life cycle of the products. Gevo uses low-carbon renewable resource-based carbohydrates as raw materials, and is in an advanced state of developing renewable electricity and renewable natural gas for use in production processes, resulting in low-carbon fuels with substantially reduced carbon intensity (the level of greenhouse gas emissions compared to standard petroleum fossil-based fuels across their life cycle). Gevo’s products perform as well or better than traditional fossil-based fuels in infrastructure and engines, but with substantially reduced greenhouse gas emissions. In addition to addressing the problems of fuels, Gevo’s technology also enables certain plastics, such as polyester, to be made with more sustainable ingredients. Gevo’s ability to penetrate the growing low-carbon fuels market depends on the price of oil and the value of abating carbon emissions that would otherwise increase greenhouse gas emissions. Gevo believes that its proven, patented technology enabling the use of a variety of low-carbon sustainable feedstocks to produce price-competitive low-carbon products such as gasoline components, jet fuel and diesel fuel yields the potential to generate project and corporate returns that justify the build-out of a multi-billion-dollar business.

Gevo believes that the Argonne National Laboratory GREET model is the best available standard of scientific-based measurement for life cycle inventory or LCI.

Learn more at Gevo’s website: www.gevo.com

Forward-Looking Statements

Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to a variety of matters, without limitation, including the Luverne Facility, the Luverne Facility’s ability to produce IBA, the Net-Zero 1 project, Gevo’s technology, Gevo’s products, and other statements that are not purely statements of historical fact. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of the management of Gevo and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and Gevo undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Although Gevo believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Gevo in general, see the risk disclosures in the Annual Report on Form 10-K of Gevo for the year ended December 31, 2020, and in subsequent reports on Forms 10-Q and 8-K and other filings made with the U.S. Securities and Exchange Commission by Gevo.

Investor and Media Contact

+1 720-647-9605

[email protected]

Release – Kratos Reports Second Quarter Financial Results


Kratos Reports Second Quarter Financial Results

 

Second Quarter Revenues of $205.1 Million, Increased 20.4 percent over Second Quarter 2020

Second Quarter Unmanned Systems Segment Revenues of $60.3 Million, Increased 43.6 percent over Second Quarter 2020

Second Quarter KGS Segment Revenues of $144.8 Million, Increased 12.8 percent over Second Quarter 2020

Second Quarter 2021 Book to Bill Ratio of 0.9 to 1
Last Twelve Months Ended June 27, 2021 Book to Bill Ratio of 1.2 to 1

SAN DIEGO
Aug. 03, 2021 (GLOBE NEWSWIRE) — 
Kratos Defense & Security Solutions, Inc. (Nasdaq:KTOS), a leading National Security Solutions provider, today reported its second quarter 2021 financial results. For the second quarter of 2021, Kratos reported Revenues of 
$205.1 million, Operating Income of 
$3.3 million, Net Income of 
$1.1 million and Adjusted EBITDA of 
$17.6 million.   Included in Kratos’ second quarter 2021 Adjusted EBITDA is approximately 
$0.4 million of a negative foreign exchange impact resulting from an increased Shekel value against the 
U.S. Dollar in Kratos’ Israeli-based microwave business. Without this adverse transaction exchange impact, second quarter 2021 Adjusted EBITDA would have been 
$18.0 million. For the second quarter of 2021, internally funded Research and Development expense increased 
$4.2 million over the second quarter of 2020 and increased 
$2.2 million sequentially over the first quarter of 2021.

Second quarter 2021 Revenues of 
$205.1 million increased 20.4 percent, as compared to Revenues of 
$170.4 million in the second quarter of 2020, reflecting organic growth in Kratos’ Unmanned Systems, Space, Satellite and Cyber, Rocket Support Systems and 
Microwave Electronics businesses, offset partially by certain reductions, including in our Training Solutions business, resulting primarily from a previously disclosed reduction in scope of certain international contracts.  

Revenue grew organically 12.3 percent in the second quarter of 2021 as compared to the second quarter of 2020, excluding the impact of the 
ASC Signal, TDI and 5D acquisitions which contributed approximately 
$13.8 million. Revenue grew organically 15.9 percent in the second quarter of 2021 on a proforma basis, excluding the impact of the acquisitions and the reduction of the international training contracts of approximately 
$4.7 million.

Operating Income of 
$3.3 million in the second quarter of 2021 increased from 
$2.9 million in the second quarter of 2020, with second quarter 2021 Operating Income including increases in non-cash stock-based compensation expense of 
$1.8 million and R&D of 
$4.2 million over the second quarter of 2020. Second Quarter 2021 Adjusted EBITDA of 
$17.6 million increased 15.0 percent, as compared to 
$15.3 million in the second quarter of 2020, primarily reflecting the increase in revenues.  

Second quarter 2021 Cash Flow Used from Operations was 
$0.7 million, and Free Cash Flow Used from Operations was 
$11.6 million, after funding 
$10.9 million of capital expenditures, including in our high growth Unmanned Systems and Space and Satellite business areas. For the six months ended 
June 27, 2021, Cash Flow Generated from Operations was 
$22.0 million, and Free Cash Flow Generated from Operations was 
$1.5 million, after funding 
$20.5 million of capital expenditures. Cash on hand at 
June 27, 2021 was 
$369.3 million. Kratos reported second quarter 2021 Net Income of 
$1.1 million, and GAAP EPS income of 
$0.01, compared to Net Loss of 
$0.7 million and GAAP EPS loss of 
$0.01 for the second quarter of 2020. Adjusted EPS was 
$0.06 for the second quarter of 2021 compared to 
$0.05 for the second quarter of 2020. The Company has approximately 
$280 million of net operating loss carryforwards, which are expected to substantially shield Kratos from paying future cash income taxes.  

For the second quarter of 2021, Kratos’ Unmanned Systems Segment (KUS) Revenues of 
$60.3 million increased 43.6 percent, as compared to 
$42.0 million in the second quarter of 2020, and KUS operating income increased by 310.0 percent, to 
$4.1 million in the second quarter of 2021 from 
$1.0 million in the second quarter of 2020.

Second quarter 2021 KUS Adjusted EBITDA of 
$6.9 million increased 130.0 percent, as compared to second quarter 2020 Adjusted EBITDA of 
$3.0 million, primarily reflecting increases in certain tactical and target drone programs and financial leverage achieved on the KUS fixed manufacturing, overhead, general and administrative cost structure as production increases, offset by certain development programs, including in the tactical drone area, which typically generate lower margins.

KUS’s book-to-bill ratio for the second quarter of 2021 was 0.4 to 1.0 and 1.0 to 1.0 for the last twelve months ended 
June 27, 2021, with bookings of 
$227.4 million for the twelve months ended 
June 27, 2021.   Total backlog for KUS at the end of the second quarter of 2021 was 
$185.4 million, down from 
$222.4 million at the end of the first quarter of 2021, and up from 
$175.7 million at the end of the second quarter of 2020.      

For the second quarter of 2021, Kratos’ Government Solutions Segment (KGS) reported Revenues of 
$144.8 million, an increase of 12.8 percent, as compared to revenues of 
$128.4 million in the second quarter of 2020, and operating income of 
$5.9 million, down from operating income of 
$7.7 million in the second quarter of 2020, primarily reflecting a less favorable revenue mix, including an increase in new development-type programs.   Revenues in the second quarter of 2021 included organic growth in our Space, Satellite and Cyber, Rocket Support Systems and Microwave Products businesses, and 
$11.8 million from the 
ASC Signal acquisition, partially offset by reductions of approximately 
$4.7 million in our Training Solutions business, resulting primarily from the previously disclosed scope reductions in certain international programs.

Kratos’ Space, Satellite and Cyber business generated Revenues of 
$67.4 million in the second quarter of 2021, an increase of 35.9 percent over the second quarter of 2020 Revenues of 
$49.6 million. Excluding ASC, our Space, Satellite and Cyber business Revenues grew 12.1 percent organically. Second quarter 2021 KGS Adjusted EBITDA of 
$10.7 million was down from second quarter 2020 Adjusted EBITDA of 
$12.3 million, primarily reflecting a less favorable mix of revenues and increased investments in R&D expenses of approximately 
$4.2 million, which were primarily incurred in the Space and Satellite business.

For the second quarter of 2021, KGS reported a book-to-bill ratio of 1.1 to 1.0, including a book-to-bill ratio of 1.3 to 1.0 in Kratos’ Space, Satellite, Cyber and Training Solutions businesses. For the twelve months ended 
June 27, 2021, KGS reported a book to bill ratio of 1.2 to 1.0, with bookings of 
$726.0 million for the twelve months ended 
June 27, 2021. KGS’s total backlog at the end of the second quarter of 2021 was 
$680.2 million, up from 
$670.5 million at the end of the first quarter of 2021, and up from 
$542.8 million at the end of the second quarter of 2020.

For the second quarter of 2021, Kratos reported consolidated bookings of 
$177.8 million and a book-to-bill ratio of 0.9 to 1.0, with consolidated bookings of 
$953.4 million and a book-to-bill ratio of 1.2 to 1.0 for the last twelve months ended 
June 27, 2021. Backlog at 
June 27, 2021 was 
$865.6 million, down sequentially from 
$892.9 million at 
March 28, 2021 and up from 
$683.4 million at 
June 26, 2020, and Kratos’ bid and proposal pipeline was 
$9.0 billion at 
June 27, 2021.   Backlog at 
June 27, 2021 was comprised of funded backlog of 
$630.6 million and unfunded backlog of 
$235.0 million.

Eric DeMarco, Kratos’ President and CEO, said, “Since our last report to you, Kratos’ UTAP-22 Mako jet drone successfully flew the Skyborg Autonomy Core System (ACS), which included Kratos’ Mako being the closest unmanned aircraft to fly with a manned fighter, an F-16 Falcon, in the history of aviation. Skyborg program related systems and payloads are now being integrated onto the first two Valkyries from our 
Oklahoma manufacturing line from the initial 12 Lot currently in production, with additional Skyborg and other program tactical drone flights, including Gremlins and Air Wolf, scheduled for the second half of this year. We believe that Kratos’ suite of Unmanned Systems, those flying today and new systems that are coming from our Ghost Works, will be transformational for our customers and our Company, as we continue to integrate various relevant payloads and systems, increasing our market leading position and progressing towards fielding and initial operating capability.”   

Mr. DeMarco continued, “In Kratos’ space and satellite business, our new software-based OpenSpace and virtualized products are experiencing significant customer penetration and acceptance, including record bookings with approximately 30 customers year to date. We are forecasting an extremely strong second half of 2021 for this business, most notably for the fourth quarter, including significant margin expansion, with this growth trajectory expected to further accelerate into 2022.”

Mr. DeMarco concluded, “Our strategy is to be first to market, with the right products, at an affordable cost, at the right time. We are focused on exceeding our customers’ expectations with new, innovative, and disruptive technology and systems and driving significant organic growth and returns for our stakeholders.”   
   
Financial Guidance

We are providing our third quarter 2021 guidance and reaffirming our previously provided full year 2021 Revenue, Adjusted EBITDA and Cash Flow guidance as follows:

$M Q321 FY21
Revenues $195 – 
$205
$810 – 
$850
R&D $9 – 
$10
$38 – 
$40
Operating Income $2 – 
$5
$27 – 
$33
Depreciation $5 – 
$6
$21 – 
$22
Amortization $2 – 
$3
$6 – 
$7
Stock Based Compensation $6 – 
$7
$25 – 
$26
Adjusted EBITDA $16 – 
$20
$81 – 
$87
Operating Cash Flow   $23– 
$28
Capital Expenditures   $58 – 
$63
Free Cash Flow Use   (
$30 – 
$40)
     


The third quarter and full year 2021 estimated Revenues and operating performance reflects the expected hardware, product and software mix based on current shipment and execution schedules. The third quarter and full year 2021 estimated Revenues also include the impact of the recent loss of a large international training contract, which contributed approximately 
$34.5 million to the Company’s full year 2020 Revenues. Our full year 2021 guidance range includes our current forecasted business mix, and our most recent assumptions of the expected impact of COVID-19, of which Kratos experienced increased employee cases at the end of 2020, which continued into 
July 2021, including in 
California
Florida and 
Oklahoma and in certain of our drone, space and satellite, turbine and C5ISR locations, and recent supplier delays. In addition, estimated third quarter and full year 2021 Operating Income and Adjusted EBITDA reflect the expected mix of development-type contracts and expected investments, primarily in our Space and Satellite, Unmanned, C5ISR and Engine businesses, where we have received or are pursuing a number of large opportunities, including Ground Based Strategic Deterrent (“GBSD”), Over Head Persistent Infrared (OPIR) and Skyborg.

The full year 2021 estimated Operating Cash Flow includes approximately 
$10 million of planned investments in our Rocket Support Systems and Engine businesses for new products, including in the Hypersonic area, and to increase Kratos’ market share, as well as approximately 
$5 million of the required payback of the 2020 deferred employer related payroll taxes. The 2021 capital expenditure forecast currently includes expected outlays of 
$20 to 
$25 million associated with the continued production of Valkyrie aircraft prior to receipt of expected customer award(s); therefore, these aircraft are currently reflected as Company-owned assets until receipt of the related customer award(s). Kratos will adjust the forecasted capital expenditure outlays and the ultimate balance sheet classification of these investments once expected customer orders and the nature of the contract terms can be determined. In addition, the capital expenditure forecast includes investments in the Company’s Space and Satellite business secure facilities and the Company-owned space domain awareness network, capital investments related to the recent GBSD award, and investments related to the Company’s Turbine and Rocket Support Systems businesses.

Management will discuss the Company’s second quarter 2021 financial results, as well as its third quarter and full year 2021 guidance on a conference call beginning at 
2:00 p.m. Pacific (
5:00 p.m. Eastern) today. Analysts and institutional investors may participate in the conference call by dialing (866) 393-0674, and referencing the call by ID number 4751019. The general public may access the conference call by dialing (877) 344-3935 or on the day of the event by visiting www.kratosdefense.com for a simultaneous webcast. A replay of the webcast will be available on the Kratos web site approximately two hours after the conclusion of the conference call.

About Kratos Defense & Security Solutions

Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS) develops and fields transformative, affordable technology, platforms, and systems for United States National Security related customers, allies, and commercial enterprises.  Kratos is changing the way breakthrough technologies for these industries are rapidly brought to market through proven commercial and venture capital backed approaches, including proactive research, and streamlined development processes.  At Kratos, affordability is a technology, and we specialize in unmanned systems, satellite communications, cyber security/warfare, microwave electronics, missile defense, hypersonic systems, training and combat systems and next generation turbo jet and turbo fan engine development. For more information go to www.kratosdefense.com.

Notice Regarding ForwardLooking Statements
This news release contains certain forward-looking statements that involve risks and uncertainties, including, without limitation, express or implied statements concerning the Company’s expectations regarding its future financial performance, including the Company’s expectations for its third quarter and full year 2021 revenue, R&D, operating income, depreciation, amortization, stock based compensation expense, and Adjusted EBITDA, and full year 2021 operating cash flow, capital expenditures and other investments, and free cash flow, the Company’s future growth trajectory and ability to achieve improved revenue mix and profit in certain of its business segments and the expected timing of such profit, the Company’s expectation of ramp on projects and that investments in its business will result in an increase in the Company’s market share and total addressable market and position the Company for significant future organic growth, profitability, cash flow and shareholder value, the Company’s bid and proposal pipeline, demand for its products and services, including the Company’s alignment with today’s National Security requirements, ability to successfully compete in the tactical unmanned aerial system area and expected new customer awards, including the magnitude and timing of funding and expected contract awards related to the Company’s Valkyrie program and other new tactical unmanned programs, performance of key contracts and programs, including the timing of production and demonstration related to certain of the Company’s contracts and product offerings, the impact of the Company’s restructuring efforts and cost reduction measures, including its ability to improve profitability and cash flow in certain business units as a result of these actions, benefits to be realized from the Company’s net operating loss carry forwards, the availability and timing of government funding for the Company’s offerings, including the strength of the future funding environment, the short-term delays that may occur as a result of Continuing Resolutions or delays in 
DoD budget approvals, timing of LRIP and full rate production related to the Company’s unmanned aerial target system offerings, as well as the level of recurring revenues expected to be generated by these programs once they achieve full rate production, market and industry developments, and the current estimated impact of COVID-19 on our financial projections, industry, business and operations, including projected growth. Such statements are only predictions, and the Company’s actual results may differ materially from the results expressed or implied by these statements. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Factors that may cause the Company’s results to differ include, but are not limited to: risks to our business and financial results related to the reductions and other spending constraints imposed on the 
U.S. Government and our other customers, including as a result of sequestration and extended continuing resolutions, the Federal budget deficit and Federal government shut-downs; risks of adverse regulatory action or litigation; risks associated with debt leverage and cost savings and cash flow improvements expected as a result of the refinancing of our Senior Notes; risks that our cost-cutting initiatives will not provide the anticipated benefits; risks that changes, cutbacks or delays in spending by the 
U.S. 
DoD may occur, which could cause delays or cancellations of key government contracts; risks of delays to or the cancellation of our projects as a result of protest actions submitted by our competitors; risks that changes may occur in Federal government (or other applicable) procurement laws, regulations, policies and budgets; risks of the availability of government funding for the Company’s products and services due to performance, cost growth, or other factors, changes in government and customer priorities and requirements (including cost-cutting initiatives, the potential deferral of awards, terminations or reduction of expenditures to respond to the priorities of 
Congress and the Administration, or budgetary cuts resulting from Congressional committee recommendations or automatic sequestration under the Budget Control Act of 2011, as amended); risks that the UAS and UGS markets do not experience significant growth; risks that we cannot expand our customer base or that our products do not achieve broad acceptance which could impact our ability to achieve our anticipated level of growth; risks of increases in the Federal government initiatives related to in-sourcing; risks related to security breaches, including cyber security attacks and threats or other significant disruptions of our information systems, facilities and infrastructures; risks related to our compliance with applicable contracting and procurement laws, regulations and standards; risks related to the new DoD Cybersecurity Maturity Model Certification (CMMC); risks relating to contract performance; risks related to failure of our products or services; risks associated with our subcontractors’ or suppliers’ failure to perform their contractual obligations, including the appearance of counterfeit or corrupt parts in our products; changes in the competitive environment (including as a result of bid protests); failure to successfully integrate acquired operations and competition in the marketplace, which could reduce revenues and profit margins; risks that potential future goodwill impairments will adversely affect our operating results; risks that anticipated tax benefits will not be realized in accordance with our expectations; risks that a change in ownership of our stock could cause further limitation to the future utilization of our net operating losses; risks that we may be required to record valuation allowances on our net operating losses which could adversely impact our profitability and financial condition; risks that the current economic environment will adversely impact our business; currently unforeseen risks associated with COVID-19 and risks related to natural disasters or severe weather. These and other risk factors are more fully discussed in the Company’s Annual Report on Form 10-K for the period ended 
December 27, 2020, and in our other filings made with the 
Securities and Exchange Commission.

Note Regarding Use of Non-GAAP Financial Measures and Other Performance Metrics

This news release contains non-GAAP financial measures, including Adjusted earnings per share (computed using income from continuing operations before income taxes, excluding income (loss) from discontinued operations, excluding income (loss) attributable to non-controlling interest, excluding depreciation, amortization of intangible assets, amortization of capitalized contract and development costs, stock-based compensation expense, acquisition and restructuring related items and other, which includes but is not limited to legal related items and foreign transaction gains and losses, less the estimated impact to income taxes) and including Adjusted EBITDA (which includes net income (loss) attributable to noncontrolling interest and excludes, among other things, losses and gains from discontinued operations, acquisition and restructuring related items, stock compensation expense, foreign transaction gains and losses, and the associated margin rates). Additional non-GAAP financial measures include Free Cash Flow from Operations computed as Cash Flow from Operations less Capital Expenditures and Adjusted EBITDA related to our KUS and KGS businesses. Kratos believes this information is useful to investors because it provides a basis for measuring the Company’s available capital resources, the actual and forecasted operating performance of the Company’s business and the Company’s cash flow, excluding non-recurring items and non-cash items that would normally be included in the most directly comparable measures calculated and presented in accordance with GAAP. The Company’s management uses these non-GAAP financial measures along with the most directly comparable GAAP financial measures in evaluating the Company’s actual and forecasted operating performance, capital resources and cash flow. Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information presented in compliance with GAAP, and investors should carefully evaluate the Company’s financial results calculated in accordance with GAAP and reconciliations to those financial statements. In addition, non-GAAP financial measures as reported by the Company may not be comparable to similarly titled amounts reported by other companies. As appropriate, the most directly comparable GAAP financial measures and information reconciling these non-GAAP financial measures to the Company’s financial results prepared in accordance with GAAP are included in this news release.

Another Performance Metric the Company believes is a key performance indicator in our industry is our Book to  Bill Ratio as it provides investors with a measure of the amount of bookings or contract awards as compared to the amount of revenues that have been recorded during the period, and provides an indicator of how much of the Company’s backlog is being burned or utilized in a certain period. The Book to  Bill Ratio is computed as the number of bookings or contract awards in the period divided by the revenues recorded for the same period. The Company believes that the rolling or last twelve months Book to  Bill Ratio is meaningful since the timing of quarter to quarter bookings can vary.

Press Contact:
Yolanda White
858-812-7302 Direct

Investor Information:
877-934-4687
[email protected]




Kratos Defense & Security Solutions, Inc.  
Unaudited Condensed Consolidated Statements of Operations  
(in millions, except per share data)  
                   
    Three Months Ended   Six Months Ended  
    June 27,   June 28,   June 27,   June 28,  
      2021       2020       2021       2020    
                   
Service revenues   $ 58.0     $ 62.9     $ 115.3     $ 126.5    
Product sales     147.1       107.5       284.0       212.8    
Total revenues     205.1       170.4       399.3       339.3    
Cost of service revenues     41.3       46.2       83.8       91.4    
Cost of product sales     111.8       78.2       212.5       156.1    
Total costs     153.1       124.4       296.3       247.5    
Gross profit – service revenues     16.7       16.7       31.5       35.1    
Gross profit – product sales     35.3       29.3       71.5       56.7    
                   
     Total gross profit     52.0       46.0       103.0       91.8    
                   
Selling, general and administrative expenses     35.6       32.7       70.9       64.2    
Acquisition and restructuring related items     0.3       1.1       0.5       1.6    
Research and development expenses     10.2       6.0       18.2       11.7    
Depreciation     1.4       1.5       2.6       3.0    
Amortization of intangible assets     1.2       1.8       2.6       3.7    
     Operating income     3.3       2.9       8.2       7.6    
Interest expense, net     (5.7 )     (5.6 )     (11.6 )     (11.0 )  
Other income (expense), net           0.3       0.2       (0.2 )  
Loss from continuing operations before income taxes     (2.4 )     (2.4 )     (3.2 )     (3.6 )  
Benefit for income taxes from continuing operations     (3.6 )     (1.8 )     (6.3 )     (3.2 )  
Income (loss) from continuing operations     1.2       (0.6 )     3.1       (0.4 )  
Loss from discontinued operations, net of income taxes     (0.3 )     (0.2 )     (0.3 )     (0.6 )  
     Net income (loss)     0.9       (0.8 )     2.8       (1.0 )  
     Less: Net loss attributable to noncontrolling interest     (0.2 )     (0.1 )     (0.2 )     (0.1 )  
     Net income (loss) attributable to Kratos   $ 1.1     $ (0.7 )   $ 3.0     $ (0.9 )  
                   
Basic income (loss) per common share attributable to Kratos:                  
     Income (loss) from continuing operations   $ 0.01     $ (0.01 )   $ 0.02     $    
     Loss from discontinued operations                       (0.01 )  
     Net income (loss)     0.01     $ (0.01 )   $ 0.02     $ (0.01 )  
                   
Diluted income (loss) per common share attributable to Kratos:                  
     Income (loss) from continuing operations   $ 0.01     $ (0.01 )   $ 0.02     $    
     Loss from discontinued operations                       (0.01 )  
     Net income (loss)   $ 0.01     $ (0.01 )   $ 0.02     $ (0.01 )  
                   
Weighted average common shares outstanding:                  
     Basic weighted average common shares outstanding     124.7       108.3       124.4       107.8    
     Diluted weighted average common shares outstanding     127.7       108.3       127.8       107.8    
                   
Adjusted EBITDA (1)   $ 17.6     $ 15.3     $ 35.7     $ 31.6    
         
                   
                   
Unaudited Reconciliation of GAAP to Non-GAAP Measures                  
                   
Note: (1) Adjusted EBITDA is a non-GAAP measure defined as GAAP net income (loss) attributable to Kratos adjusted for net income (loss)      
attributable to noncontrolling interest, income (loss) from discontinued operations, net interest expense, provision for income taxes, depreciation and      
amortization expense of intangible assets, amortization of capitalized contract and development costs, stock-based compensation,          
acquisition and restructuring related items and other, and foreign transaction gain (loss).                  
                   
                   
Adjusted EBITDA as calculated by us may be calculated differently than Adjusted EBITDA for other companies. We have provided          
Adjusted EBITDA because we believe it is a commonly used measure of financial performance in comparable companies and is provided to      
help investors evaluate companies on a consistent basis, as well as to enhance understanding of our operating results. Adjusted EBITDA      
should not be construed as either an alternative to net income or as an indicator of our operating performance or an alternative to cash flows      
as a measure of liquidity. The adjustments to calculate this non-GAAP financial measure and the basis for such adjustments are outlined below.      
Please refer to the following table below that reconciles GAAP net income (loss) to Adjusted EBITDA.              
                   
The adjustments to calculate this non-GAAP financial measure, and the basis for such adjustments, are outlined below:          
                   
Interest income and interest expense, net. The Company receives interest income on investments and incurs interest expense on loans, capital leases and  
other financing arrangements, including the amortization of issue discounts and deferred financing costs. These amounts may vary from period to period  
due to changes in cash and debt balances.                  
                   
Income taxes. The Company’s tax expense can fluctuate materially from period to period due to tax adjustments that may not be directly related to      
underlying operating performance or to the current period of operations and may not necessarily reflect the impact of utilization of our NOLs.      
                   
Depreciation. The Company incurs depreciation expense (recorded in cost of revenues and in operating expenses) related to capital assets purchased,      
leased or constructed to support the ongoing operations of the business. The assets are recorded at cost or fair value and are depreciated over the estimated  
useful lives of individual assets.                  
                   
Amortization of intangible assets. The Company incurs amortization of intangible expense related to acquisitions it has made. These intangible assets are  
valued at the time of acquisition and are amortized over the estimated useful lives.                  
                   
Amortization of capitalized contract and development costs. The Company incurs amortization of previously capitalized software development and non-    
recurring engineering costs related to certain targets in its Unmanned Systems and ballistic missile target businesses as these units are sold.      
                   
Stock-based compensation expense. The Company incurs expense related to stock-based compensation included in its GAAP presentation of selling,      
general and administrative expense. Although stock-based compensation is an expense of the Company and viewed as a form of compensation, these      
expenses vary in amount from period to period, and are affected by market forces that are difficult to predict and are not within the control of management,  
such as the market price and volatility of the Company’s shares, risk-free interest rates and the expected term and forfeiture rates of the awards.      
Management believes that exclusion of these expenses allows comparison of operating results to those of other companies that disclose non-GAAP      
financial measures that exclude stock-based compensation.                  
                   
Foreign transaction (gain) loss. The Company incurs transaction gains and losses related to transactions with foreign customers in currencies other than    
the 
U.S. dollar. In addition, certain intercompany transactions can give rise to realized and unrealized foreign currency gains and losses.
     
                   
Acquisition and transaction related items. The Company incurs transaction related costs, such as legal and accounting fees and other expenses, related to  
acquisitions and divestiture activities. Management believes these items are outside the normal operations of the Company’s business and are not      
indicative of ongoing operating results.                  
                   
Restructuring costs. The Company incurs restructuring costs for cost reduction actions which include employee termination costs,          
facility shut-down related costs and remaining lease commitment costs for excess or exited facilities. Management believes that these costs are not      
indicative of ongoing operating results as they are either non-recurring and/or not expected when full capacity and volumes are achieved.      
                   
Legal related items. The Company incurs costs related to pending legal settlements and other legal related matters. Management believes      
these items are outside the normal operations of the Company’s business and are not indicative of ongoing operating results.          
                   
Adjusted EBITDA is a non-GAAP financial measure and should not be considered in isolation or as a substitute for financial information provided in      
accordance with GAAP. This non-GAAP financial measure may not be computed in the same manner as similarly titled measures used by other      
companies. The Company expects to continue to incur expenses similar to the Adjusted EBITDA financial adjustments described above, and investors      
should not infer from the Company’s presentation of this non-GAAP financial measure that these costs are unusual, infrequent, or non-recurring.      
                   
Reconciliation of Net income attributable to Kratos to Adjusted EBITDA is as follows:                  
                   
    Three Months Ended   Six Months Ended  
    June 27,   June 28,   June 27,   June 28,  
      2021       2020       2021       2020    
                   
Net income (loss) attributable to Kratos   $ 1.1     $ (0.7 )   $ 3.0     $ (0.9 )  
Loss from discontinued operations, net of income taxes     0.3       0.2       0.3       0.6    
Interest expense, net     5.7       5.6       11.6       11.0    
Benefit for income taxes from continuing operations     (3.6 )     (1.8 )     (6.3 )     (3.2 )  
Depreciation (including cost of service revenues and product sales)     5.8       4.2       10.7       8.6    
Stock-based compensation     6.6       4.8       12.8       9.5    
Foreign transaction (gain) loss     0.1       (0.1 )     0.2       0.3    
Amortization of intangible assets     1.2       1.8       2.6       3.7    
Amortization of capitalized contract and development costs     0.3       0.3       0.5       0.5    
Acquisition and restructuring related items and other     0.3       1.1       0.5       1.6    
Plus: Net loss attributable to noncontrolling interest     (0.2 )     (0.1 )     (0.2 )     (0.1 )  
                   
Adjusted EBITDA   $ 17.6     $ 15.3     $ 35.7     $ 31.6    
                   
                   
                   
Reconciliation of acquisition and restructuring related items and other included in Adjusted EBITDA:              
    Three Months Ended   Six Months Ended  
    June 27,   June 28,   June 27,   June 28,  
      2021       2020       2021       2020    
Acquisition and transaction related items   $ 0.1     $ 1.0     $ 0.3     $ 1.4    
Restructuring costs     0.2       0.1       0.2       0.2    
                   
    $ 0.3     $ 1.1     $ 0.5     $ 1.6    
                   
                   
Kratos Defense & Security Solutions, Inc.  
Unaudited Segment Data  
(in millions)  
                   
    Three Months Ended   Six Months Ended  
    June 27,   June 28,   June 27,   June 28,  
      2021       2020       2021       2020    
Revenues:                  
Unmanned Systems   $ 60.3     $ 42.0     $ 116.2     $ 84.0    
Kratos Government Solutions     144.8       128.4       283.1       255.3    
Total revenues   $ 205.1     $ 170.4     $ 399.3     $ 339.3    
                   
Operating income                  
Unmanned Systems   $ 4.1     $ 1.0     $ 8.3     $ 1.5    
Kratos Government Solutions     5.9       7.7       13.0       17.0    
Unallocated corporate expense, net     (6.7 )     (5.8 )     (13.1 )     (10.9 )  
Total operating income   $ 3.3     $ 2.9     $ 8.2     $ 7.6    
                   
Note: Unallocated corporate expense, net includes costs for certain stock-based compensation programs (including stock-based compensation costs for stock options, employee stock purchase plan and restricted stock units), the effects of items not considered part of management’s evaluation of segment operating performance, and acquisition and restructuring related items, corporate costs not allocated to the segments, legal related items, and other miscellaneous corporate activities.  
                   
Reconciliation of Segment Operating Income to Adjusted EBITDA is as follows:                  
                   
    Three Months Ended   Six Months Ended  
    June 27,   June 28,   June 27,   June 28,  
      2021       2020       2021       2020    
Unmanned Systems                  
Operating income   $ 4.1     $ 1.0     $ 8.3     $ 1.5    
Other income           0.1       0.1       0.1    
Depreciation     2.2       1.4       3.8       3.0    
Amortization of intangible assets     0.3       0.2       0.6       0.2    
Amortization of capitalized contract and development costs     0.3       0.3       0.5       0.5    
Acquisition and restructuring related items and other                          
Adjusted EBITDA   $ 6.9     $ 3.0     $ 13.3     $ 5.3    
% of revenue     11.4 %     7.1 %     11.4 %     6.3 %  
                   
Kratos Government Solutions                  
Operating income   $ 5.9     $ 7.7     $ 13.0     $ 17.0    
Other income     0.1       0.1       0.3          
Depreciation     3.6       2.8       6.9       5.6    
Amortization of intangible assets     0.9       1.6       2.0       3.5    
Amortization of capitalized contract and development costs                          
Acquisition and restructuring related items and other     0.2       0.1       0.2       0.2    
Adjusted EBITDA   $ 10.7     $ 12.3     $ 22.4     $ 26.3    
% of revenue     7.4 %     9.6 %     7.9 %     10.3 %  
                   
Total Adjusted EBITDA   $ 17.6     $ 15.3     $ 35.7     $ 31.6    
% of revenue     8.6 %     9.0 %     8.9 %     9.3 %  
                   
                   
                   
                   
                   
Kratos Defense & Security Solutions, Inc.  
Unaudited Condensed Consolidated Balance Sheets  
(in millions)  
                   
           
            June 27,   December 27,  
              2021       2020    
Assets                  
Current assets:                  
Cash and cash equivalents           $ 369.3     $ 380.8    
Restricted cash                   0.7    
Accounts receivable, net             265.0       272.3    
Inventoried costs             90.7       81.2    
Prepaid expenses             13.4       12.0    
Other current assets             30.3       17.8    
Total current assets             768.7       764.8    
Property, plant and equipment, net             145.5       143.8    
Operating lease right-of-use assets             40.1       42.9    
Goodwill             483.7       483.9    
Intangible assets, net             40.4       43.0    
Other assets             83.9       84.4    
Total assets           $ 1,562.3     $ 1,562.8    
Liabilities and Stockholders’ Equity                  
Current liabilities:                  
Accounts payable           $ 59.9     $ 55.4    
Accrued expenses             27.2       34.7    
Accrued compensation             46.2       48.1    
Accrued interest             1.5       1.5    
Billings in excess of costs and earnings on uncompleted contracts             43.5       34.0    
Current portion of operating lease liabilities             9.3       8.9    
Other current liabilities             11.8       11.9    
Other current liabilities of discontinued operations             2.7       3.1    
Total current liabilities             202.1       197.6    
Long-term debt             300.3       301.0    
Operating lease liabilities, net of current portion             35.3       38.6    
Other long-term liabilities             71.6       83.0    
Other long-term liabilities of discontinued operations             2.5       2.5    
Total liabilities             611.8       622.7    
Commitments and contingencies                  
Redeemable noncontrolling interest             14.6       14.8    
Stockholders’ equity:                  
Additional paid-in capital             1,563.1       1,556.3    
Accumulated other comprehensive loss             2.2       1.4    
Accumulated deficit             (629.4 )     (632.4 )  
Total Kratos stockholders’ equity             935.9       925.3    
Total liabilities and stockholders’ equity           $ 1,562.3     $ 1,562.8    
                   
                   
                   
Kratos Defense & Security Solutions, Inc.  
Unaudited Condensed Consolidated Statements of Cash Flows  
(in millions)  
                   
        Six Months Ended  
            June 27,   June 28,  
              2021       2020    
Operating activities:                  
Net income (loss)           $ 2.8     $ (1.0 )  
Less: loss from discontinued operations             (0.3 )     (0.6 )  
Income (loss) from continuing operations             3.1       (0.4 )  
Adjustments to reconcile income (loss) from continuing operations to net cash provided by operating activities from continuing operations:                  
Depreciation and amortization             13.3       12.3    
Amortization of lease right-of-use assets             4.5       5.3    
Deferred income taxes             (0.9 )     (1.1 )  
Stock-based compensation             12.8       9.5    
Amortization of deferred financing costs             0.5       0.5    
Provision for (recovery of) doubtful accounts             (0.2 )     0.2    
Changes in assets and liabilities, net of acquisitions:                  
Accounts receivable             15.5       24.7    
Unbilled receivables             (7.9 )     (6.8 )  
Inventoried costs             (6.8 )     (4.5 )  
Prepaid expenses and other assets             (2.2 )     (10.8 )  
Operating lease liabilities             (4.5 )     (6.0 )  
Accounts payable             5.8       (9.1 )  
Accrued compensation             (1.8 )     1.4    
Accrued expenses             (7.5 )     (4.2 )  
Accrued interest                      
Billings in excess of costs and earnings on uncompleted contracts             9.6       (0.5 )  
Income tax receivable and payable             (6.1 )     (3.0 )  
Other liabilities             (5.2 )     3.3    
Net cash provided by operating activities from continuing operations             22.0       10.8    
Investing activities:                  
Cash paid for acquisitions, net of cash acquired             (6.2 )     (15.5 )  
Capital expenditures             (20.5 )     (14.1 )  
 Proceeds from sale of assets                   0.1    
Net cash used in investing activities from continuing operations             (26.7 )     (29.5 )  
Financing activities:                  
Payment of long-term debt                   (0.1 )  
Proceeds from the issuance of common stock, net of issuance costs                   240.5    
Payment under finance leases             (0.4 )     (0.3 )  
Payments of employee taxes withheld from share-based awards             (8.5 )        
Proceeds from shares issued under equity plans             2.5       1.4    
Net cash provided by (used in) financing activities from continuing operations             (6.4 )     241.5    
Net cash flows from continuing operations             (11.1 )     222.8    
   Net operating cash flows of discontinued operations             (0.8 )     1.7    
Effect of exchange rate changes on cash and cash equivalents             (0.3 )     0.1    
Net increase (decrease) in cash, cash equivalents and restricted cash             (12.2 )     224.6    
Cash, cash equivalents and restricted cash at beginning of period             381.5       172.6    
Cash, cash equivalents and restricted cash at end of period           $ 369.3     $ 397.2    
                   
                   
                   
Kratos Defense & Security Solutions, Inc.  
Unaudited Non-GAAP Measures  
Computation of Adjusted Earnings Per Share  
(in millions, except per share data)  
                   
                   
Adjusted income from continuing operations and adjusted income from continuing operations per diluted common share (Adjusted EPS) are non-GAAP      
measures for reporting financial performance and exclude the impact of certain items and, therefore, have not been calculated in accordance with GAAP. Management  
believes that exclusion of these items assists in providing a more complete understanding of the Company’s underlying continuing operations results and trends and allows
for comparability with our peer company index and industry. The Company uses these measures along with the corresponding GAAP financial measures    
to manage the Company’s business and to evaluate its performance compared to prior periods and the marketplace. The Company defines adjusted      
income from continuing operations before amortization of intangible assets, depreciation, stock-based compensation, foreign transaction gain/loss, and    
acquisition and restructuring related items and other. The estimated impact to income taxes includes the impact to the effective tax rate, current tax provision and  
deferred tax provision, and excludes the impact of discrete items, including transaction related expenses and release of valuation allowance, or benefit related to the add-backs.*
Adjusted EPS reflects adjusted income on a per share basis using weighted average diluted shares outstanding.              
                   
The following table reconciles the most directly comparable GAAP financial measures to the non-GAAP financial measures.          
                   
    Three Months Ended   Six Months Ended  
    June 27,   June 28,   June 27,   June 28,  
      2021       2020       2021       2020    
Net income (loss) attributable to Kratos   $ 1.1     $ (0.7 )   $ 3.0     $ (0.9 )  
Less: GAAP benefit for income taxes     (3.6 )     (1.8 )     (6.3 )     (3.2 )  
Less: Net loss attributable to noncontrolling interest     (0.2 )     (0.1 )     (0.2 )     (0.1 )  
Less: Loss from discontinued operations, net of income taxes     0.3       0.2       0.3       0.6    
Loss from continuing operations before taxes     (2.4 )     (2.4 )       (3.2 )     (3.6 )  
Add: Amortization of intangible assets     1.2       1.8         2.6       3.7    
Add: Amortization of capitalized contract and development costs     0.3       0.3       0.5       0.5    
Add: Depreciation     5.8       4.2       10.7       8.6    
Add: Stock-based compensation     6.6       4.8       12.8       9.5    
Add: Foreign transaction (gain) loss     0.1       (0.1 )     0.2       0.3    
Add: Acquisition and restructuring related items and other     0.3       1.1       0.5       1.6    
   Non-GAAP Adjusted income from continuing operations before income taxes     11.9       9.7       24.1       20.6    
Income taxes on Non-GAAP measure Adjusted income from continuing operations*     4.3       4.0       8.8       8.3    
   Non-GAAP Adjusted net income   $ 7.6     $ 5.7     $ 15.3     $ 12.3    
                   
                   
Diluted earnings per common share   $ 0.01     $ (0.01 )   $ 0.02     $ (0.01 )  
Less: GAAP benefit for income taxes     (0.03 )     (0.02 )     (0.05 )     (0.03 )  
Less: Net loss attributable to noncontrolling interest                          
Less: Loss from discontinued operations, net of income taxes                       0.01    
Add: Amortization of intangible assets     0.01       0.02       0.02       0.03    
Add: Amortization of capitalized contract and development costs           0.01       0.01       0.01    
Add: Depreciation     0.05       0.04       0.08       0.08    
Add: Stock-based compensation     0.05       0.04       0.10       0.09    
Add: Foreign transaction (gain) loss                          
Add: Acquisition and restructuring related items and other           0.01       0.01       0.01    
Income taxes on Non-GAAP measure Adjusted income from continuing operations*     (0.03 )     (0.04 )     (0.07 )     (0.08 )  
Adjusted income from continuing operations per diluted common share   $ 0.06     $ 0.05     $ 0.12     $ 0.11    
                   
Weighted average diluted common shares outstanding     127.7       108.3       127.8       107.8    
                   
*The impact to income taxes is calculated by recasting income before income taxes to include the add-backs involved in determining Adjusted income from continuing
operations before income taxes and recalculating the income tax provision (benefit), including current and deferred income taxes, using the Adjusted income from continuing
operations before income taxes. The recalculation also adjusts for any discrete tax expense, including transaction related expenses and the release of valuation allowance, or
benefit related to the add-backs.

Source: Kratos Defense & Security Solutions, Inc.

Townsquare Media Inc (TSQ) – A Recovery For The Record

Wednesday, August 04, 2021

Townsquare Media Inc (TSQ)
A Recovery For The Record

Townsquare Media Inc is an entertainment and media company offering digital marketing solutions in the United States and Canada. It owns and operates radio stations, social media properties focusing the small and mid-cap companies. Services offered to the clients include live events, local advertising, digital advertising, e-commerce offerings, few others. The segments through which the company operates its businesses are classified into Local marketing solutions and Entertainment segments. Revenues are generated from commercials through broadcasts and sale of internet based advertisements.

Michael Kupinski, Director of Research, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    Q2 exceeds expectations. Total revenues of $107.3 million beat our estimate of $102.5 million, with the largest upside in local marketing solutions. Adjusted EBITDA was $30.3 million, an all time record, versus our $28.3 million estimate, benefiting from higher gross margins (33.3% versus our 32.7% estimate). Notably, the company’s Digital businesses were strong, with Townsquare Interactive adding a record number of 1,350 net new subscribers and revenues up nearly 20%.

    Operating near pre-Covid levels.  The company’s revenue and EBITDA recovery has been remarkable, with revenues roughly 98% of pre-covid levels, excluding its hard hit Entertainment business. Based on recent 2021 revenue and adj. EBITDA guidance, the company is expected to be near full recovery, with full year 2021 EBITDA guidance actually better than 2019 levels …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Kratos Defense Security (KTOS) – Solid 2Q21 Sets Up A Strong 2H21

Wednesday, August 04, 2021

Kratos Defense & Security (KTOS)
Solid 2Q21 Sets Up A Strong 2H21

Kratos Defense & Security Solutions is a National Security technology provider with proprietary expertise in the area of unmanned aerial vehicles, electronics for missile defense systems, electronic warfare systems, satellite control and management systems and support services for emerging naval weapon systems. Commercial and state and local government revenues are about 25% of the total and comprise primarily of critical infrastructure monitoring and protection systems.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    2Q21 Results. Kratos 2Q21 results came in at the high end of guidance. Revenues were $205.1 million, adjusted EPS was $0.06, and adjusted EBITDA for the quarter was $17.6 million. We had forecast revenue of $200 million, adjusted EPS of $0.05, and $16.0 million of adjusted EBITDA. Consensus was at $199 million of revenue and adjusted EPS of $0.06.

    Opportunity Abounds.  Kratos continues to be blessed with a strong opportunity set. It is not a question of if, in our opinion, but of when. Just in the second half of this year, Kratos could receive awards from the Air Force and Navy for target drones, a confidential program, an international target award, and an engine award. And the number and scope of programs being contemplated as the DoD …



This research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Great Lakes Dredge Dock (GLDD) – Tough 1H2021 With COVID-19 But 2H2021 Rebound Ahead

Wednesday, August 04, 2021

Great Lakes Dredge & Dock (GLDD)
Tough 1H2021 With COVID-19, But 2H2021 Rebound Ahead

Great Lakes Dredge & Dock Corp is a provider of dredging services in the United States. The company only’s operating segments is Dredging. Dredging involves the enhancement or preservation of navigability of waterways or the protection of shorelines through the removal or replenishment of soil, sand or rock. Its projects portfolio includes Coastal Restoration, Coastal Protection, Port expansion, and others.

Poe Fratt, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    2Q2021 EBITDA of $20 million was dragged down by higher costs and downtime/delays due to COVID-19. For the second consecutive quarter, 2Q2021 operating results were softer than expected due to COVID-19 disruptions and unexpected downtime. Despite increasing vaccination rates amongst crews, extensive testing and preventive measures, several vessels were sidelined and scheduling was disrupted again. The number of days of downtime was not quantified, but extra direct costs totaled $3.0 million, which compares to 23 days of downtime and extra direct costs of $4.3 million in 1Q2021.

    Fine tuning 2021 EBITDA estimate.  1H2021 start slow due to COVID-19 issues, but 2H2021 should recover. Our EBITDA estimate of $132.3 million is lower than our previous estimate of $146 million and down compared to 2020 EBITDA of $151.1 million due to a 300 basis point drop in EBITDA margin to 17.6%, mainly due to strong outperformance on several projects last year and the negative impact of …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Should the Market Continue To be Concerned with Covid Cases?



The Combined Wisdom of the Stock Market Seems to Say “Covid is so 2020”

 

Stock performance seems to be in contradiction to the uproar in mainstream media and some social media as they report stats on rising Covid-19 cases. It seems like once a week, markets break record highs, and it has been over a year since the S&P 500 has dropped by 5% or more. This indicates that investors are feeling positive as they look forward to corporate earnings and U.S. economic growth during the remainder of 2021.

Headlines Ignored

After a year and a half of what is presumably the worst of everything that comes with this virus, individual investors that weigh probabilities of whether a stock will go up or down may be relying on recent history that suggests the worst didn’t turn out bad for their portfolios. For professionals that are expected to maximize risk/return performance, they are better able to defend performance numbers because they were “fully” invested rather than keeping cash on the sidelines.

Fear-inducing reports that last year could have led to selling are taken in stride mid-year 2021 So much so that even when broadcast and print news are highlighting that a more contagious variation of Covid-19 is making its way around, the market reaches all-time highs. There is widespread reporting that those inoculated to make them immune to Covid may not be able to avoid being infected with mutations from the original. Examples include the nine Olympians that were inoculated but could not compete because they tested positive for Covid. Making headlines in the U.S.,  of the 469 new cases in the county containing Cape Cod, Massachusetts, 74% were in people who’d been given a Covid shot. As states and localities determine if they should clamp down on citizens and businesses, market participants seem to be saying, “it can’t be as bad as last year” and “…Last year the market ended terrific.” So Covid may be viewed as a positive by some investors, many new traders that are helping move the market may not know how to trade without the news volatility and added liquidity of a prolonged pandemic.

Statistics

Coming into Monday (August 2), the seven-day average of new Covid cases in the U.S. was approximately 80,000, up 129% since the seven-day period ending July 19. S&P 500 and Dow Jones Industrial Average futures, however, were up about 0.5% and 0.4%, respectively. The “Covid trade” may be losing its power.

 

Take-Away

We live in a global economy. The worldwide seven-day average of new Covid cases is about 596,000, up only 15% from the seven-day period ending July 19. That is from a number that is well off its peak and certainly better than the reported U.S. 129% figure.  Excluding the U.S. figures, the worldwide seven-day average is about 517,000, up 6% from the level on July 19. Every day 3700 people around the globe are killed in traffic accidents, many more are seriously hurt. The market has become accustomed to those figures; perhaps they are growing accustomed to living with this additional threat.

Register for Channelchek, no uproar, simply level reporting.

 

Suggested Content



Higher Foot Traffic in Lower Vaccination States



Long Term Retirement Money and Fledgling Companies





The Seeking Alpha Paywall Causes Frustration



Train the Body’s Own Cells to Combat Microbiotic Resistance

 

Sources

https://www.medpagetoday.com/infectiousdisease/covid19vaccine/93830

https://www.medpagetoday.com/infectiousdisease/covid19vaccine/93830

 

Stay up to date. Follow us:

 

Would a 25 Percent Tax on Marijuana Encourage Illegal Dealing?



What’s in the Senate’s Marijuana Tax Proposal

 

Is a nationwide excise tax of 25% on marijuana the right number? The 163-page “discussion draft” presented in the Senate suggests that it is. Is that in line with other prescription and over-the-counter pharmaceuticals? Is it in line with other “vice” products like alcohol, cigarettes, and coffee? Would a 25% tax push marijuana sales back in the shadows of fast-food parking lots and street corners? We look at what’s between 163 pages and explore these questions below.

 

Benefits

The draft bill of Senate Majority Leader Chuck Schumer’s federal marijuana reform legislation would set a nationwide cannabis excise tax initially at 10%, it then rises to 25% in five years. In exchange, The Cannabis Administration and Opportunity Act would unchain marijuana from federal roadblocks and hurdles by removing marijuana from the federal Controlled Substance Act. This does not include any state tax levies.

The top benefits of the proposal are that it would allow the industry to participate in the banking process similar to other industries and also allow cannabis businesses to deduct expenses provided to other legal industries (eliminate IRS compliance with Section 280E).

Comparisons

Other pharmaceuticals, including pain relievers that are sold over the counter, are taxed on a state level, and many states make them exempt. Coffee is taxed if prepared and served in most states but falls under the food category of taxation if bought at a grocer. Most groceries are not taxed directly from the consumer by the state or federal government. The federal excise tax on cigarettes and other tobacco products is just over $1.00 per pack. Large cigars are taxed at 52.75 percent of the manufacturer’s sales price, with a maximum tax of 40.26 cents per cigar. Federal tax rates on alcohol are progressive; for distilled spirits, the government charges $2.70 per proof gallon on the first 100,000 proof gallons in production. Then, a tax rate of $13.34 per proof gallon for the next 22,130,000 proof gallons in production. This increases to $13.50 per proof gallon for production in excess of 22,230,000 proof gallons. Although some see marijuana and alcohol in the same light, current-day medical doctors don’t prescribe distilled spirits for any malady.

For marijuana, beginning in year five, the tax would be levied on a per-ounce rate for cannabis flower or a per-milligram of THC rate for extracts. The rate would be determined by the U.S. Secretary of the Treasury to be equivalent to 25% of the revenue received from cannabis sold in the U.S. in the prior year. Producers with more than $20 million in sales would be eligible for a tax credit on their first $20 million of cannabis sold annually. Sales above that amount would be subject to the full excise tax. Mathematically, some growers might prefer their crop to remain federally illegal with full 280e restrictions on deductions.

If conditions of the draft bill are enacted, regulatory responsibility of marijuana would be transferred from the U.S. Drug Enforcement Agency (DEA) to the Alcohol and Tobacco Tax and Trade Bureau (TTB), and the Bureau of Alcohol Tobacco Firearms and Explosives (ATF). 

The draft Bill is 163 pages of legalese. It represents the thinking of the party in control (drafted by Senator Schumer, NY and Senator Booker, CA) it should be understood and awaits comments from stakeholders. Below is a synopsis.

Cannabis Draft Bill Summary

  • Decriminalization of Cannabis, Recognition State laws Have Control
    • This section removes cannabis from the Controlled Substances Act.
    • It transfers agency jurisdiction from the DEA to the TTB, and ATF. This jurisdiction would follow the same agency responsibilities established for alcohol and tobacco
    • Recognition that state laws control the possession, production, and distribution of marijuana. It retains criminal penalties in the case of unlawful possession, production, distribution, or purchase of cannabis
    • The bill authorizes the establishment of regulations to track and trace the manufacture and transport of cannabis products
    • Authorization to the Secretary of Health and Human Services to continue to include cannabis for drug testing of Federal employees
  • Research, Prevention, and Training
    • Directs the Comptroller General to conduct an evaluation for Congress on the societal impact of legalization by states. It is specifically related to the adult-use of cannabis-related to -related deaths and violent crime
    • Directs the Dept. of Health and Human Services to research the effects of cannabis on health conditions
    • The Department of Transportation would be directed to supply statistics on cannabis-impaired driving to foster the creation of an impairment standard for driving under the influence
  • Allows the Administrator to provide guarantees for loans to eligible cannabis small businesses or service providers.
  • Restorative Justice and Opportunity Initiatives
    • Requires expungement of federal non-violent marijuana convictions and resentencing within one year of enactment and encourages states to follow suit.
  • Taxation of Cannabis and Establishment of Trust Fund
    • Requires a federal permit to sell cannabis products wholesale.
    • Imposes an excise tax on cannabis products, similar to tobacco. The draft suggests 10% for the year of enactment, to be increased annually by 5% each year for 5 years. After 5 years, the tax would be levied on a per-ounce rate.
  • Public Health, Cannabis Administration, and Trade Practices
    • Creates a legal pathway for CBD in dietary supplements and outlines the FDA’s ability to regulate cannabis distribution based on administration standards similar to current regulations for drugs and devices.

The draft is requesting comments on issues such as the necessary funding levels and resources for agencies to implement the bill, consideration of transition rules and effective dates, interactions with state and local laws and international obligations and treaties, and additional opportunities to expand restorative justice.

Take-Away

Changes are afoot in the federal government concerning cannabis. Investors will find that altered regulation and acceptance impact the bottom line of the companies they are invested in. Not missing a new legislative proposal or enactment means watching the feds activity from various sources. Register free for Channelchek to receive our insight daily in your inbox.

 

Paul Hoffman

Managing Editor, Channelchek

 

Suggested Reading:



The Cannabis Administration and Opportunity Act Would Open Doors



Marijuana and Sports, Where Officials Stand





Clarence Thomas Statement on “Half in / Half out” Marijuana Laws



Will Federal Law Surrounding Marijuana be Changed?

 

Sources:

https://www.democrats.senate.gov/imo/media/doc/Cannabis%20Administration%20and%20Opportunity%20Act.pdf

https://www.democrats.senate.gov/newsroom/press-releases/majority-leader-schumer-senate-finance-committee-chair-wyden-and-senator-booker-release-discussion-draft-of-cannabis-administration-and-opportunity-act-legislation-to-end-the-federal-cannabis-prohibition-and-unfair-targeting-of-communities-of-color

https://www.forbes.com/sites/kellyphillipserb/2016/09/29/12-quirky-facts-about-coffee-tax-on-national-coffee-day/?sh=63af49d45b91

https://center-forward.org/explaining-alcohol-excise-taxes/

https://www.cbo.gov/budget-options/56869
https://www.cdc.gov/statesystem/factsheets/excisetax/ExciseTax.html
https://www.pwc.com/gx/en/pharma-life-sciences/pdf/ph2020_tax_times_final.pdf

https://www.taxpolicycenter.org/briefing-book/what-are-major-federal-excise-taxes-and-how-much-money-do-they-raise

 

Stay up to date. Follow us:

 

Release – Esports Entertainment Group Launches New Pay-and-Play Casino Brand Targeting the Finnish Market

 


Esports Entertainment Group Launches New Pay-and-Play Casino Brand Targeting the Finnish Market

 

Newark, New Jersey–(Newsfile Corp. – August 3, 2021) – Esports Entertainment Group, Inc. (NASDAQ: GMBL) (NASDAQ: GMBLW) (or the “Company”), an esports entertainment and online gambling company, today announced the upcoming launch of Fiksukasino.com, a “pay-and-play” online casino brand targeting the Finnish gaming market. The Company’s Lucky Dino business has already experienced great success in Finland and is once again at the forefront of understanding player appetite in the region.

“Pay and play” is a rapidly growing concept in the online gaming industry that allows a player to bypass onerous registration processes, enabling safe and reliable play without delay. The smooth registration experience puts Fiksukasino in pole position when it comes to traffic sources and scaling customer acquisition.

“We are very excited for Lucky Dino to be launching this new brand. Bypassing the registration flow creates a much smoother and seamless experience for the player, offering instant deposit and withdrawals,” said Grant Johnson, CEO of Esports Entertainment Group. “This latest launch is a testament to the Lucky Dino team’s market awareness and product innovation and strengthens the foundations in a key market for the company.”

The Finnish gaming industry grew an estimated 9% in 2020 reaching nearly US$3 billion.

About Esports Entertainment Group

Esports Entertainment Group is a full stack esports and online gambling company fueled by the growth of video-gaming and the ascendance of esports with new generations. Our mission is to help connect the world at large with the future of sports entertainment in unique and enriching ways that bring fans and gamers together. Esports Entertainment Group and its affiliates are well-poised to help fans and players to stay connected and involved with their favorite esports. From traditional sports partnerships with professional NFL/NHL/NBA/FIFA teams, community-focused tournaments in a wide range of esports, and boots-on-the-ground LAN cafes, EEG has influence over the full-spectrum of esports and gaming at all levels. The Company maintains offices in New Jersey, the UK and Malta. For more information visit www.esportsentertainmentgroup.com.

FORWARD-LOOKING STATEMENTS

The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.

Contact:

U.S. Investor Relations
RedChip Companies, Inc.
Dave Gentry
407-491-4498
[email protected]

Media & Investor Relations Inquiries
[email protected]

Release – Euroseas Ltd. Announces New Charter for One Of Its Vessels MV EM Spetses


Euroseas Ltd. Announces New Charter for One Of Its Vessels, M/V “EM Spetses”

 

ATHENS, Greece, Aug. 02, 2021 (GLOBE NEWSWIRE) — Euroseas Ltd. (NASDAQ: ESEA, the “Company” or “Euroseas”), an owner and operator of container vessels and provider of seaborne transportation for containerized cargoes, announced today a new time charter contract for its container vessel M/V “EM Spetses”.

Specifically, M/V “EM Spetses”, a 1,740 TEU vessel built in 2007, entered into a new time charter contract for a period between a minimum of thirty-six (36) and a maximum of forty (40) months at the option of the charterer, at a gross daily rate of $29,500. The new rate will commence on August 5, 2021 when the vessel is redelivered from its current charterer.

Aristides Pittas, Chairman and CEO of Euroseas commented: “We are pleased to announce the new charter for our vessel, M/V “EM Spetses”, for about three years at a rate about three and a half times the level of its current employment. EM Spetses’ new daily rate of $29,500 is the second highest rate earned by a vessel in our fleet and, notably, by one of our smallest vessels. This fixture follows the fixture of our M/V “EM Hydra”, a sister vessel of M/V “EM Spetses” built in 2005, that was fixed about three months ago for an approximately two-year long charter at a gross daily rate of $20,000 indicating how strongly the market has risen in the span of just three months. This new charter will secure us with a minimum of $31 million of contracted revenues and have a minimum EBITDA contribution of approximately $24 million. At the same time, Euroseas is well positioned to take advantage of a further rising market with four more ships, about 30% of our fleet on-the-water, which are expected to open up till the end of the year.”

Fleet Profile:

The Euroseas Ltd. fleet profile is as follows:

Name Type Dwt TEU Year
Built
Employment(*) TCE Rate ($/day)

Container Carriers
           
AKINADA BRIDGE (*) Intermediate 71,366 5,610 2001 TC until Oct-21
plus 10-12
months option
$17,250; option
$20,000
SYNERGY BUSAN (+) Intermediate 50,726 4,253 2009 TC until Aug-21 /
TC until Aug-24
$12,000
$25,000
SYNERGY ANTWERP (*) Intermediate 50,726 4,253 2008 TC until Sep-23 $18,000
SYNERGY OAKLAND (*) Intermediate 50,787 4,253 2009 TC until Jun-21 CONTEX(1) 4,250
less 10% i.e.
$64,660 from of
7/22/21 until
10/22/21
SYNERGY KEELUNG (+) Intermediate 50,969 4,253 2009 TC until Jun-22
plus 8- 12
months option
$10,000 until Jun-
21; $11,750 until
Jun-22; option
$14,500
EM KEA (*) Feeder 42,165 3,100 2007 TC until May-23 $22,000
EM ASTORIA (+) Feeder 35,600 2,788 2004 TC until Feb-22 $18,650
EVRIDIKI G (+) Feeder 34,677 2,556 2001 TC until Jan-22 $15,500
EM CORFU (*) Feeder 34,654 2,556 2001 TC until Sep-21 $10,200
DIAMANTIS P (+) Feeder 30,360 2,008 1998 TC until Aug-21 $6,500
EM SPETSES (+) Feeder 23,224 1,740 2007 TC until Aug-24 $29,500
EM HYDRA (*) Feeder 23,351 1,740 2005 TC until April-23 $20,000
JOANNA (*) Feeder 22,301 1,732 1999 TC until Oct-22 $16,800
AEGEAN  EXPRESS (*) Feeder 18,581 1,439 1997 TC until Mar-22 $11,500

Total Fleet “on-the-water”
14 539,487 42,281      
Newbuildings Type Dwt TEU TBD(2)    
H4201 Feeder 37,237 2,800 Q1 ‘23  –
H4202 Feeder 37,237 2,800 Q2 ‘23  –
Total Fleet(3) 16 613,961 47,881      

Notes
(*) / (+) TC denotes time charter. All dates listed are the earliest redelivery dates under each time charter unless the contract rate is lower than the current market rate in which cases the latest redelivery date is assumed; vessels with the latest redelivery date shown are marked by (+).
(1) The CONTEX (Container Ship Time Charter Assessment Index) has been published by the Hamburg and Bremen Shipbrokers’ Association (VHBS) since October 2007. The CONTEX is a company-independent index of time charter rates for container ships. It is based on assessments of the current day charter rates of six selected container ship types, which are representative of their size categories: Type 1,100 TEU and Type 1,700 TEU with a charter period of one year, and the Types 2,500, 2,700, 3,500 and 4,250 TEU, all with a charter period of two years.
(2) Calendar quarter vessel is scheduled to be delivered (“TBD”)
(3) On a fully delivered basis

About Euroseas Ltd.
Euroseas Ltd. was formed on May 5, 2005 under the laws of the Republic of the Marshall Islands to consolidate the ship owning interests of the Pittas family of Athens, Greece, which has been in the shipping business over the past 140 years. Euroseas trades on the NASDAQ Capital Market under the ticker ESEA. 

Euroseas operates in the container shipping market. Euroseas’ operations are managed by Eurobulk Ltd., an ISO 9001:2008 and ISO 14001:2004 certified affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. Euroseas employs its vessels on spot and period charters and through pool arrangements. 

The Company has a fleet of 14 vessels on the water, including 9 Feeder containerships and 5 Intermediate Container carriers and two feeder ships under newbuilding contracts. After the delivery of the latter two vessels, Euroseas 16 containerships will have a cargo capacity of 47,881 teu.

Forward Looking Statement
This press release contains forward-looking statements (as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended) concerning future events and the Company’s growth strategy and measures to implement such strategy; including expected vessel acquisitions and entering into further time charters. Words such as “expects,” “intends,” “plans,” “believes,” “anticipates,” “hopes,” “estimates,” and variations of such words and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that such expectations will prove to have been correct. These statements involve known and unknown risks and are based upon a number of assumptions and estimates that are inherently subject to significant uncertainties and contingencies, many of which are beyond the control of the Company. Actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to changes in the demand for containerships, competitive factors in the market in which the Company operates; risks associated with operations outside the United States; and other factors listed from time to time in the Company’s filings with the Securities and Exchange Commission. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based. 

Visit our website www.euroseas.gr

Company Contact Investor Relations / Financial Media
Tasos Aslidis
Chief Financial Officer
Euroseas Ltd.
11 Canterbury Lane,
Watchung, NJ 07069
Tel. (908) 301-9091
E-mail: [email protected]
Nicolas Bornozis
President
Capital Link, Inc.
230 Park Avenue, Suite 1536
New York, NY 10169
Tel. (212) 661-7566
E-mail: [email protected]

Release – Sierra Metals Subsidiary in Peru Sociedad Minera Corona Reports Q2-2021 Financial Results


Sierra Metals Subsidiary in Peru, Sociedad Minera Corona Reports Q2-2021 Financial Results

 

Sierra Metals’ Consolidated Financial Results Will Be Released on August 9, 2021

(All metal prices reported in USD)

TORONTO–(BUSINESS WIRE)– Sierra Metals Inc. (TSX:SMT) (BVL:SMT) (NYSE AMERICAN:SMTS) (“Sierra Metals” or “the Company”) announces the filing of Sociedad Minera Corona S.A.’s (“Corona”) unaudited Financial Statements and the Management Discussion and Analysis (“MD&A”) for the second quarter of 2021 (“Q2 2021”).

The Company holds an 81.8% interest in Corona. All amounts are presented in US dollars unless otherwise stated and have not been adjusted for the 18.2% non-controlling interest.

Corona’s Highlights for the Three Months Ended June 30, 2021

  • Revenues of US$50.8 million, a 117% increase from Q2 2020.
  • Adjusted EBITDA of US$25.9 million, a 231% increase from Q2 2020.
  • Total tonnes processed of 328,909, a 62% increase from Q2 2020.
  • Net production revenue per tonne of ore milled increased by 42% to US$151.51.
  • Copper equivalent pounds production increased 7% to 15.3 million pounds.
    Cash Cost per copper equivalent payable pound higher by 55% to US$1.41. All-in sustaining cost (“AISC”) per copper equivalent payable pound higher by 42% to US$2.57.
  • Zinc equivalent pounds production increased 29% to 49.9 million pounds.
    Cash cost per zinc equivalent payable pound higher by 28% to US$0.43. All-in sustaining cost (“AISC”) per zinc equivalent payable pound higher by 18% to US$0.79.
  • $72.5 million of cash and cash equivalents as at June 30, 2021.
  • $102.2 million of working capital as at June 30, 2021.

The Yauricocha mine processed 328,909 tonnes during the second quarter Q2 2021, representing an increase of 62% over the Q2 2020, despite continuing to face several operational challenges related to COVID-19. During the quarter, the treatment capacity in the concentrator plant was increased, obtaining improvements in efficiency and utilization.

Metal grades were negatively impacted during Q2 2021 due to the delays in the contribution from the Esperanza zone due to ground conditions, which have since been addressed and controlled.

Metal production for Q2 2021 was 54%, 35%, 23% and 22% higher for zinc, silver, gold and lead, respectively, while copper production was 11% lower compared to the same quarter of 2020.

Luis Marchese, CEO of Sierra Metals, commented, The Yauricocha Mine had a relatively strong quarter with increases in throughput, revenue and net income over the same period in 2020 and over the previous quarter in 2021. The Mine continues to deal with operational difficulties related to COVID-19, however, we are managing the impact using best practices. Our goal continues to be avoiding any mine closure while ensuring that strict protocols remain in place to protect the wellbeing of our employees and the local communities.”

He continued,“Looking ahead at the remainder of 2021 we have received the final permit required to expand the throughput at Yauricocha to 3,600 tonnes per day. We continue to work on the completion of a Preliminary Feasibility Study to support the planned expansion to 5,500 tonnes per day at the Yauricocha Mine. Brownfield and greenfield explorations programs are ongoing, and we continue to work to improve operations and manage costs in this challenging environment.”

He concluded, Minera Corona and the Yauricocha Mine continues to have a strong balance sheet to support the Company’s capital expenditures and growth initiatives, and we continue to work to improve per share value for all shareholders.

The following table displays selected unaudited financial information for the three and six months ended June 30, 2021:

(In thousands of US dollars, except cash cost and revenue Three Months Ended

 

Six Months Ended

 

per tonne metrics) June 30, 2021 June 30, 2020

Var %

June 30, 2021 June 30, 2020

Var %

 

 

Revenue $

50,830

 

23,405

 

117%

92,755

 

57,123

 

62%

Adjusted EBITDA (1)

25,851

 

7,805

 

231%

42,024

 

17,583

 

139%

Cash Flow from operations

25,620

 

7,263

 

253%

42,116

 

17,319

 

143%

Gross profit

25,774

 

8,562

 

201%

41,923

 

17,530

 

139%

Income Tax Expense

(9,111

)

(2,939

)

210%

(15,953

)

(7,709

)

107%

Net Income

12,554

 

1,849

 

579%

17,729

 

3,909

 

354%

 

 

Net production revenue per tonne of ore milled (2)

151.51

 

106.53

 

42%

139.86

 

113.36

 

23%

Cash cost per tonne of ore milled (2)

61.35

 

44.27

 

39%

60.89

 

59.44

 

2%

 

 

 

Cash cost per copper equivalent payable pound (2)

1.41

 

0.91

 

55%

1.45

 

1.06

 

36%

All-In Sustaining Cost per copper equivalent payable pound (2)

2.57

 

1.80

 

42%

2.62

 

2.05

 

28%

Cash cost per zinc equivalent payable pound (2)

0.43

 

0.34

 

28%

0.45

 

0.39

 

15%

All-In Sustaining Cost per zinc equivalent payable pound (2) $

0.79

 

0.67

 

18%

0.82

 

0.76

 

9%

 

 

(In thousands of US dollars, unless otherwise stated) June 30, 2021 December 31, 2020

 

 

 

 

Cash and cash equivalents $

72,549

 

65,027

 

 

 

Assets

262,392

 

235,263

 

 

 

Liabilities

62,873

 

53,473

 

 

 

Equity

199,519

 

181,790

 

 

 

(1) Adjusted EBITDA includes adjustments for depletion and depreciation, interest expense and other financing costs, interest income, share-based compensation, Foreign Exchange (gain) loss and income taxes; see non-IFRS Performance Measures section of the Company’s MD&A.

(2) All-In Sustaining Cost per copper equivalent pound and All-In Sustaining Cost per zinc equivalent pound sold are non-IFRS performance measures and include the cost of sales, treatment and refining charges, sustaining capital expenditures, general and administrative expense, and selling expense, and exclude workers’ profit sharing, depreciation, and other non-cash provisions; Cash cost copper equivalent pound sold and cash cost per zinc equivalent pound sold, net production revenue per tonne of ore milled, and cash cost per tonne of ore milled are non-IFRS performance measures; see non-IFRS Performance Measures section of the Company’s MD&A.

The following table displays average realized metal prices information for the three and six months ended June 20, 2021, vs June 30, 2020:

Average realized prices  

Three months ended June 30,

Increase

Six months ended June 30,

Increase

In US$  

2021

2020

(%)

2021

2020

(%)

Silver ($/oz)  

26.80

16.59

62%

26.62

16.58

61%

Copper ($/lb)  

4.37

2.40

82%

4.13

2.46

68%

Zinc ($/lb)  

1.34

0.89

51%

1.29

0.91

42%

Lead ($/lb)  

0.97

0.76

28%

0.94

0.78

21%

Gold ($/oz)  

1,818

1,722

6%

1,798

1,654

9%

Corona’s Financial Highlights for the Three and Six Months Ended June 30, 2021

  • Q2 2021 revenue of $50.8 million compared to $23.4 million for the same quarter of 2020. Sales for the quarter increased mainly due to higher metal prices and the application of new commercial copper terms since April 2021 that more than offset the lower amounts of metals sold compared to the second quarter of 2020. Revenue for H1 2021 was $92.8 million, which is an increase of 62% from the $57.1 million of revenues in H1 2020. The increase in revenues was driven mainly by higher average realized metal prices and decrease in treatment and refining charges as compared to H1 2020.
  • Cash Cost per copper equivalent payable pound was $1.41 compared to $0.91 for the same quarter of 2020 ($1.45 for H1 2021 versus $1.06 in H1 2020). Cash Cost per zinc equivalent payable pound was $0.43 compared to $0.34 for the same quarter of 2020 ($0.45 for H1 2021 versus $0.39 in H1 2020).
  • AISC per copper equivalent payable pound was $ 2.57 for the second quarter of 2021 compared to $ 1.80 for the same period of 2020. AISC per zinc equivalent payable pound was $0.79 compared to $0.67 for the same period of 2020. AISC increased during Q2 2021 as the increase in the equivalent payable metals could not offset the increase in costs. Copper equivalent payable pounds increased 5% to 13.8 million and zinc equivalent payable pounds increased 26% to 45.2 million compared to the same quarter of 2020. Sustaining capital investment was significantly higher as the Company resumed its capital projects, whereas in Q2 2020, capital projects were deferred or cancelled due the problems related to COVID.
    For H1 2021, AISC per copper equivalent payable pound was $2.62 as compared to $2.05 in H1 2020. The increase was driven by higher cost of production and 11% decrease in copper equivalent payable pounds as compared to the six-month period of 2020. AISC per zinc equivalent payable pound was $0.82 as compared to $0.76 in H1 2020, as a 5% increase in the zinc equivalent payable pounds partially offset the increase in costs. Sustaining costs for H1 2021 included a 6% decline in treatment and refining costs.
  • Adjusted EBITDA of $25.9 million for Q2 2021 as compared to $7.8 million for the same quarter of 2020 and $42.0 million for H1 2021 as compared to $17.6 million for H1 2020, higher primarily due to increased net income from higher metal prices.
  • Operating cash flows before movements in working capital of $25.6 million for Q2 2021, compared to $7.3 million for Q2 2020. The increase in operating cash flows before movements in working capital was primarily due to the increase in revenues, discussed previously. For the six-month period of 2021, operating cash flows before movements in working capital increased to $42.1 million from $17.3 million during the same period of 2020.
  • Cash and cash equivalents of $72.5 million as at June 30, 2021, compared to $65.0 million as at December 31, 2020. Cash and cash equivalents increased due to $14.9 million of cash generated from operating activities partially offset by $7.3 million of cash used in investing activities and $3.1 million used in financing activities.
  • Net income of $12.6 million, or $0.349 per share for Q2 2021 ($17.7 million or $0.493 per share for H1 2021) compared to net income of $1.8 million, or $0.051 per share for Q2 2020 ($3.9 million or $0.11 per share for H1 2020).

Corona’s Operational Highlights for the Three and Six Months Ended June 30, 2021:

The following table displays the production results for the three and six months ended June 30, 2021:

Yauricocha Production

Three Months Ended June 30

Six Months Ended June 30

2021

2020

% Var.

2021

2020

% Var.

 
Tonnes processed

328,909

202,534

62%

655,120

487,759

34%

Daily throughput

3,759

2,315

62%

3,744

2,787

34%

 
 
Silver grade (g/t)

56.94

66.37

-14%

55.65

66.07

-16%

Copper grade

0.70%

1.21%

-42%

0.63%

1.17%

-46%

Lead grade

1.20%

1.63%

-26%

1.27%

1.59%

-20%

Zinc grade

3.27%

3.48%

-6%

3.49%

3.74%

-7%

Gold Grade (g/t)

0.45

0.62

-27%

0.44

0.66

-33%

 
Silver recovery

80.14%

82.82%

-3%

79.70%

82.82%

-4%

Copper recovery

72.67%

77.19%

-6%

69.84%

77.19%

-10%

Lead recovery

90.14%

88.08%

2%

90.15%

88.08%

2%

Zinc recovery

89.23%

88.32%

1%

89.82%

88.32%

2%

Gold Recovery

21.99%

21.18%

4%

20.91%

21.18%

-1%

 
 
Silver production (000 oz)

483

358

35%

934

853

9%

Copper production (000 lb)

3,697

4,164

-11%

6,379

9,548

-33%

Lead production (000 lb)

7,831

6,406

22%

16,537

15,014

10%

Zinc production (000 lb)

21,133

13,741

54%

45,256

35,387

28%

Gold Production (oz)

1,043

850

23%

1,933

2,104

-8%

 
 
Copper equivalent pounds (000’s)(1)

15,308

14,354

7%

31,142

34,549

-10%

Zinc equivalent pounds (000’s)(1)

49,923

38,723

29%

99,701

93,404

7%

 

(1) Copper and zinc equivalent pounds for Q2 2021 were calculated using the following realized prices: $26.80/oz Ag, $4.37/lb Cu, $1.34/lb Zn, $0.97/lb Pb, $1,818/oz Au. Copper and zinc equivalent pounds for Q2 2020 were calculated using the following realized prices: $16.59/oz Ag, $2.40/lb Cu, $0.89/lb Zn, $0.76/lb Pb, $1,722/oz Au. Copper and zinc equivalent pounds for 6M 2021 were calculated using the following realized prices: $26.62/oz Ag, $4.13/lb Cu, $1.29/lb Zn, $0.94/lb Pb, $1,798/oz Au. Copper and zinc equivalent pounds for 6M 2020 were calculated using the following realized prices: $16.58/oz Ag, $2.46/lb Cu, $0.91/lb Zn, $0.78/lb Pb, $1,654/oz Au.
(2) The increase in copper equivalent pounds was lower than the increase in zinc equivalents due to the 82% increase in realized prices for copper ($4.37/lb in Q2 2021 versus $2.40/lb in Q2 2020) as compared to the 51% increase in realized prices for zinc ($1.34/lb in Q2 2021 versus $0.89/lb in Q2 2020)

Quality Control

The contents of this press release have been reviewed by Américo Zuzunaga, FAusIMM CP (Mining Engineer) and Vice President of Corporate Planning, who is a Qualified Person under National Instrument 43-101 – Standards of Disclosure for Mineral Projects.

About Sierra Metals

Sierra Metals Inc. is a diversified Canadian mining company focused on the production and development of precious and base metals from its polymetallic Yauricocha Mine in Peru, and Bolivar and Cusi Mines in Mexico. The Company is focused on increasing production volume and growing mineral resources. Sierra Metals has recently had several new key discoveries and still has many more exciting brownfield exploration opportunities at all three Mines in Peru and Mexico that are within close proximity to the existing mines. Additionally, the Company also has large land packages at all three mines with several prospective regional targets providing longer-term exploration upside and mineral resource growth potential.

The Company’s Common Shares trade on the Toronto Stock Exchange and the Bolsa de Valores de Lima under the symbol “SMT” and on the NYSE American Exchange under the symbol “SMTS”.

For further information regarding Sierra Metals, please visit www.sierrametals.com.

Continue to Follow, Like and Watch our progress:

Web: www.sierrametals.com | Twitter: sierrametals | Facebook: SierraMetalsInc | LinkedIn: Sierra Metals Inc | Instagram: sierrametals

Forward-Looking Statements

This press release contains “forward-looking information” and “forward-looking statements” within the meaning of Canadian and U.S. securities laws related to the Company (collectively, “forward-looking information”). Forward-looking information includes, but is not limited to, statements with respect to the Company’s operations, including anticipated developments in the Company’s operations in future periods, the Company’s planned exploration activities, the adequacy of the Company’s financial resources, and other events or conditions that may occur in the future. Statements concerning mineral reserve and resource estimates may also be considered to constitute forward-looking statements to the extent that they involve estimates of the mineralization that will be encountered if and when the properties are developed or further developed. These statements relate to analyses and other information that are based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as “expects”, “anticipates”, “plans”, “projects”, “estimates”, “assumes”, “intends”, “strategy”, “goals”, “objectives”, “potential” or variations thereof, or stating that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved, or the negative of any of these terms and similar expressions) are not statements of historical fact and may be forward-looking information.

Forward-looking information is subject to a variety of risks and uncertainties, which could cause actual events or results to differ from those reflected in the forward-looking information, including, without limitation, the risks described under the heading “Risk Factors” in our Annual Information Form dated March 18, 2021 in respect of the year ended December 31, 2020 and other risks identified in the Company’s filings with Canadian securities regulators and the U.S. Securities and Exchange Commission, which filings are available at www.sedar.com and www.sec.gov, respectively.

The risk factors referred to above is not exhaustive of the factors that may affect any of the Company’s forward-looking information. Forward looking information includes statements about the future and are inherently uncertain, and the Company’s actual achievements or other future events or conditions may differ materially from those reflected in the forward-looking information due to a variety of risks, uncertainties and other factors. The Company’s statements containing forward-looking information are based on the beliefs, expectations and opinions of management on the date the statements are made, and the Company does not assume any obligation to update forward-looking information if circumstances or management’s beliefs, expectations or opinions should change, other than as required by applicable law. For the reasons set forth above, one should not place undue reliance on forward-looking information.

Mike McAllister
V.P., Investor Relations
Sierra Metals Inc.
+1 (416) 366-7777
[email protected]

Ed Guimaraes
CFO
Sierra Metals Inc.
+1(416) 366-7777

Luis Marchese
CEO
Sierra Metals Inc.
+1(416) 366-7777

Source: Sierra Metals Inc.

Release – Charity Holman Promoted to General Manager of WVVA in Bluefield WV


Charity Holman Promoted to General Manager of WVVA in Bluefield, WV

 

ATLANTA, Aug. 03, 2021 (GLOBE NEWSWIRE) — Gray Television, Inc. (“Gray”) (NYSE: GTN) has promoted Charity Holman to the position of General Manager of WVVA (NBC) in Bluefield, West Virginia. Charity succeeds Frank Brady, who recently retired as the station’s General Manager after more than 15 years with the television station and 47 years in broadcasting. Gray became the owner of WVVA upon its acquisition of Quincy Media, Inc. yesterday.

Since joining WVVA in September 2006, Charity has held a number of sales positions for the station. She has served as the station’s General Sales Manager since 2014, and she added the position Station Manager to her responsibilities in January 2019. In her new role, Charity will maintain her role as General Sales Manager.

Charity has long been active in the local community. She has served as an Executive Board member on the Chamber of Commerce of the Two Virginias for the last five years. Charity also serves on the Board of Directors for the Mercer County Child Protect. She received the “Volunteer of the Year” award from the Princeton Mercer County Chamber of Commerce in 2011.

Charity started her career in newspaper after graduating from Concord University with a B.A. in Communications with concentrations in Public Relations, Advertising, Broadcasting and Journalism.

About Gray Television:

Gray Television, headquartered in Atlanta, Georgia, is the largest owner of top-rated local television stations and digital assets in the United States.  Upon its anticipated acquisition of the television stations of Meredith Corporation, Gray will become the nation’s second largest television broadcaster, with television stations serving 113 markets that reach approximately 36 percent of US television households.  The pro forma portfolio includes 79 markets with the top-rated television station and 101 markets with the first and/or second highest rated television station according to Comscore’s audience measurement data.  Gray also owns video program production, marketing, and digital businesses including Raycom Sports, Tupelo Honey, and RTM Studios, the producer of PowerNation programs and content and is the majority owner of Swirl Films.

Contact Data

Kevin P. Latek, Executive Vice President, Chief Legal and Development Officer, 404-266-8333